@article{grass2024,
    author = "Grass, Tobias and Dokuzluoglu, Zeynep and Buchner, Felix and Rosignol, Ines and Thomas, Joshua and Caldarelli, Antonio and Dalinskaya, Anna and Becker, Jutta and Rost, Fabian and Marass, Michele and Wirth, Brunhilde and Beyer, Marc and Bonaguro, Lorenzo and Rodriguez-Muela, Natalia and Knoll, Rainer and Helbig, Elisa T and Dahm, Kilian and Bolaji, Olufemi and Hamm, Frederik and Dietrich, Oliver and van Uelft, Martina and Müller, Sophie and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Petrov, Lev and Krämer, Benjamin and Kraut, Michael and Stubbemann, Paula and Thibeault, Charlotte and Brumhard, Sophia and Theis, Heidi and Hack, Gudrun and De Domenico, Elena and Nattermann, Jacob and Becker, Matthias and Beyer, Marc D and Hillus, David and Georg, Philipp and Loers, Constantin and Tiedemann, Janina and Tober-Lau, Pinkus and Lippert, Lena and Millet Pascual-Leone, Belén and Tacke, Frank and Rohde, Gernot and Suttorp, Norbert and Witzenrath, Martin and Saliba, Antoine-Emmanuel and Ulas, Thomas and Polansky, Julia K and Sawitzki, Birgit and Sander, Leif E and Schultze, Joachim L and Aschenbrenner, Anna C and Kurth, Florian and Leidner, Jacqueline and Theis, Heidi and Kraut, Michael and Ragogna, Alice and Beyer, Marc and Schultze, Joachim and Schulte-Schrepping, Jonas and Carraro, Caterina and Bonaguro, Lorenzo and Budden, Kurtis F and Shukla, Shakti D and Bowerman, Kate L and Vaughan, Annalicia and Gellatly, Shaan L and Wood, David L A and Lachner, Nancy and Idrees, Sobia and Rehman, Saima Firdous and Faiz, Alen and Patel, Vyoma K and Donovan, Chantal and Alemao, Charlotte A and Shen, Sj and Amorim, Nadia and Majumder, Rajib and Vanka, Kanth S and Mason, Jazz and Haw, Tatt Jhong and Tillet, Bree and Fricker, Michael and Keely, Simon and Hansbro, Nicole and Belz, Gabrielle T and Horvat, Jay and Ashhurst, Thomas and van Vreden, Caryn and McGuire, Helen and Fazekas de St Groth, Barbara and King, Nicholas J C and Crossett, Ben and Cordwell, Stuart J and Bonaguro, Lorenzo and Schultze, Joachim L and Hamilton-Williams, Emma E and Mann, Elizabeth and Forster, Samuel C and Cooper, Matthew A and Segal, Leopoldo N and Chotirmall, Sanjay H and Collins, Peter and Bowman, Rayleen and Fong, Kwun M and Yang, Ian A and Wark, Peter A B and Dennis, Paul G and Hugenholtz, Philip and Hansbro, Philip M and Knoll, Rainer and Bonaguro, Lorenzo and Dos Santos, Jéssica C and Warnat-Herresthal, Stefanie and Jacobs-Cleophas, Maartje C P and Blümel, Edda and Reusch, Nico and Horne, Arik and Herbert, Miriam and Nuesch-Germano, Melanie and Otten, Twan and van der Heijden, Wouter A and van de Wijer, Lisa and Shalek, Alex K and Händler, Kristian and Becker, Matthias and Beyer, Marc D and Netea, Mihai G and Joosten, Leo A B and van der Ven, Andre J A M and Schultze, Joachim L and Aschenbrenner, Anna C and Carraro, Caterina and Bonaguro, Lorenzo and Srinivasa, Rachana and van Uelft, Martina and Isakzai, Victoria and Schulte-Schrepping, Jonas and Gambhir, Prerna and Elmzzahi, Tarek and Montgomery, Jessica V and Hayer, Hannah and Li, Yuanfang and Theis, Heidi and Kraut, Michael and Mahbubani, Krishnaa T and Aschenbrenner, Anna C and König, Ireen and Fava, Eugenio and Fried, Hans-Ulrich and De Domenico, Elena and Beyer, Marc and Saglam, Adem and Schultze, Joachim L and Baßler, Kevin and Schmidleithner, Lisa and Shakiba, Mehrnoush Hadaddzadeh and Elmzzahi, Tarek and Köhne, Maren and Floess, Stefan and Scholz, Rebekka and Ohkura, Naganari and Sadlon, Timothy and Klee, Kathrin and Neubauer, Anna and Sakaguchi, Shimon and Barry, Simon C and Huehn, Jochen and Bonaguro, Lorenzo and Ulas, Thomas and Beyer, Marc and Kapellos, Theodore S and Baßler, Kevin and Fujii, Wataru and Nalkurthi, Christina and Schaar, Anna C and Bonaguro, Lorenzo and Pecht, Tal and Galvao, Izabela and Agrawal, Shobhit and Saglam, Adem and Dudkin, Erica and Frishberg, Amit and de Domenico, Elena and Horne, Arik and Donovan, Chantal and Kim, Richard Y and Gallego-Ortega, David and Gillett, Tessa E and Ansari, Meshal and Schulte-Schrepping, Jonas and Offermann, Nina and Antignano, Ignazio and Sivri, Burcu and Lu, Wenying and Eapen, Mathew S and van Uelft, Martina and Osei-Sarpong, Collins and van den Berge, Maarten and Donker, Hylke C and Groen, Harry J M and Sohal, Sukhwinder S and Klein, Johanna and Schreiber, Tina and Feißt, Andreas and Yildirim, Ali Önder and Schiller, Herbert B and Nawijn, Martijn C and Becker, Matthias and Händler, Kristian and Beyer, Marc and Capasso, Melania and Ulas, Thomas and Hasenauer, Jan and Pizarro, Carmen and Theis, Fabian J and Hansbro, Philip M and Skowasch, Dirk and Schultze, Joachim L and Aschenbrenner, Anna C and Bonaguro, Lorenzo and Shakiba, Mehrnoush Hadaddzadeh and Gemünd, Ioanna and Beyer, Marc and Bonaguro, Lorenzo and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Carraro, Caterina and Sun, Laura L and Reiz, Benedikt and Gemünd, Ioanna and Saglam, Adem and Rahmouni, Souad and Georges, Michel and Arts, Peer and Hoischen, Alexander and Joosten, Leo A B and van de Veerdonk, Frank L and Netea, Mihai G and Händler, Kristian and Mukherjee, Sach and Ulas, Thomas and Schultze, Joachim L and Aschenbrenner, Anna C and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Ulas, Thomas and Aschenbrenner, Anna C and Beyer, Marc and Schultze, Joachim L and Carraro, Caterina and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Horne, Arik and Oestreich, Marie and Warnat-Herresthal, Stefanie and Helbing, Tim and De Franco, Michele and Haendler, Kristian and Mukherjee, Sach and Ulas, Thomas and Gandin, Valentina and Goettlich, Richard and Aschenbrenner, Anna C and Schultze, Joachim L and Gatto, Barbara and Baßler, Kevin and Fujii, Wataru and Kapellos, Theodore S and Dudkin, Erika and Reusch, Nico and Horne, Ari and Reiz, Benedikt and Luecken, Malte D and Osei-Sarpong, Collins and Warnat-Herresthal, Stefanie and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Wagner, Allon and Günther, Patrick and Pizarro, Carmen and Schreiber, Tina and Knoll, Rainer and Holsten, Lisa and Kröger, Charlotte and De Domenico, Elena and Becker, Matthias and Händler, Kristian and Wohnhaas, Christian T and Baumgartner, Florian and Köhler, Meike and Theis, Heidi and Kraut, Michael and Wadsworth, Marc H 2nd and Hughes, Travis K and Ferreira, Humberto J and Hinkley, Emily and Kaltheuner, Ines H and Geyer, Matthias and Thiele, Christoph and Shalek, Alex K and Feißt, Andreas and Thomas, Daniel and Dickten, Henning and Beyer, Marc and Baum, Patrick and Yosef, Nir and Aschenbrenner, Anna C and Ulas, Thomas and Hasenauer, Jan and Theis, Fabian J and Skowasch, Dirk and Schultze, Joachim L and Georg, Philipp and Astaburuaga-García, Rosario and Bonaguro, Lorenzo and Brumhard, Sophia and Michalick, Laura and Lippert, Lena J and Kostevc, Tomislav and Gäbel, Christiane and Schneider, Maria and Streitz, Mathias and Demichev, Vadim and Gemünd, Ioanna and Barone, Matthias and Tober-Lau, Pinkus and Helbig, Elisa T and Hillus, David and Petrov, Lev and Stein, Julia and Dey, Hannah-Philine and Paclik, Daniela and Iwert, Christina and Mülleder, Michael and Aulakh, Simran Kaur and Djudjaj, Sonja and Bülow, Roman D and Mei, Henrik E and Schulz, Axel R and Thiel, Andreas and Hippenstiel, Stefan and Saliba, Antoine-Emmanuel and Eils, Roland and Lehmann, Irina and Mall, Marcus A and Stricker, Sebastian and Röhmel, Jobst and Corman, Victor M and Beule, Dieter and Wyler, Emanuel and Landthaler, Markus and Obermayer, Benedikt and von Stillfried, Saskia and Boor, Peter and Demir, Münevver and Wesselmann, Hans and Suttorp, Norbert and Uhrig, Alexander and Müller-Redetzky, Holger and Nattermann, Jacob and Kuebler, Wolfgang M and Meisel, Christian and Ralser, Markus and Schultze, Joachim L and Aschenbrenner, Anna C and Thibeault, Charlotte and Kurth, Florian and Sander, Leif E and Blüthgen, Nils and Sawitzki, Birgit and Langkabel, Jan and Horne, Arik and Bonaguro, Lorenzo and Holsten, Lisa and Hesse, Tatiana and Knaus, Alexej and Riedel, Yannick and Becker, Matthias and Händler, Kristian and Elmzzahi, Tarek and Bassler, Kevin and Reusch, Nico and Yeghiazarian, Leon Harootoonovtch and Pecht, Tal and Saglam, Adem and Ulas, Thomas and Aschenbrenner, Anna C and Kaiser, Franziska and Kubaczka, Caroline and Schultze, Joachim L and Schorle, Hubert and Krämer, Benjamin and Knoll, Rainer and Bonaguro, Lorenzo and ToVinh, Michael and Raabe, Jan and Astaburuaga-García, Rosario and Schulte-Schrepping, Jonas and Kaiser, Kim Melanie and Rieke, Gereon J and Bischoff, Jenny and Monin, Malte B and Hoffmeister, Christoph and Schlabe, Stefan and De Domenico, Elena and Reusch, Nico and Händler, Kristian and Reynolds, Gary and Blüthgen, Nils and Hack, Gudrun and Finnemann, Claudia and Nischalke, Hans D and Strassburg, Christian P and Stephenson, Emily and Su, Yapeng and Gardner, Louis and Yuan, Dan and Chen, Daniel and Goldman, Jason and Rosenstiel, Philipp and Schmidt, Susanne V and Latz, Eicke and Hrusovsky, Kevin and Ball, Andrew J and Johnson, Joe M and Koenig, Paul-Albert and Schmidt, Florian I and Haniffa, Muzlifah and Heath, James R and Kümmerer, Beate M and Keitel, Verena and Jensen, Björn and Stubbemann, Paula and Kurth, Florian and Sander, Leif E and Sawitzki, Birgit and Aschenbrenner, Anna C and Schultze, Joachim L and Nattermann, Jacob and Kern, Paul and Balzer, Nora R and Blank, Nelli and Cygon, Cornelia and Wunderling, Klaus and Bender, Franziska and Frolov, Alex and Sowa, Jan-Peter and Bonaguro, Lorenzo and Ulas, Thomas and Homrich, Mirka and Kiermaier, Eva and Thiele, Christoph and Schultze, Joachim L and Canbay, Ali and Bauer, Reinhard and Mass, Elvira and Warnat-Herresthal, Stefanie and Schultze, Hartmut and Shastry, Krishnaprasad Lingadahalli and Manamohan, Sathyanarayanan and Mukherjee, Saikat and Garg, Vishesh and Sarveswara, Ravi and Händler, Kristian and Pickkers, Peter and Aziz, N Ahmad and Ktena, Sofia and Tran, Florian and Bitzer, Michael and Ossowski, Stephan and Casadei, Nicolas and Herr, Christian and Petersheim, Daniel and Behrends, Uta and Kern, Fabian and Fehlmann, Tobias and Schommers, Philipp and Lehmann, Clara and Augustin, Max and Rybniker, Jan and Altmüller, Janine and Mishra, Neha and Bernardes, Joana P and Krämer, Benjamin and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and De Domenico, Elena and Siever, Christian and Kraut, Michael and Desai, Milind and Monnet, Bruno and Saridaki, Maria and Siegel, Charles Martin and Drews, Anna and Nuesch-Germano, Melanie and Theis, Heidi and Heyckendorf, Jan and Schreiber, Stefan and Kim-Hellmuth, Sarah and Nattermann, Jacob and Skowasch, Dirk and Kurth, Ingo and Keller, Andreas and Bals, Robert and Nürnberg, Peter and Rieß, Olaf and Rosenstiel, Philip and Netea, Mihai G and Theis, Fabian and Mukherjee, Sach and Backes, Michael and Aschenbrenner, Anna C and Ulas, Thomas and Breteler, Monique M B and Giamarellos-Bourboulis, Evangelos J and Kox, Matthijs and Becker, Matthias and Cheran, Sorin and Woodacre, Michael S and Goh, Eng Lim and Schultze, Joachim L and Reusch, Nico and De Domenico, Elena and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Baßler, Kevin and Schultze, Joachim L and Aschenbrenner, Anna C and Beckert, Vera and Rassmann, Sebastian and Kayvanjoo, Amir Hossein and Klausen, Christina and Bonaguro, Lorenzo and Botermann, Dominik Simon and Krause, Melanie and Moreth, Kristin and Spielmann, Nadine and da Silva-Buttkus, Patricia and Fuchs, Helmut and Gailus-Durner, Valerie and de Angelis, Martin Hrabě and Händler, Kristian and Ulas, Thomas and Aschenbrenner, Anna C and Mass, Elvira and Wachten, Dagmar and Aschenbrenner, Anna C and Mouktaroudi, Maria and Krämer, Benjamin and Oestreich, Marie and Antonakos, Nikolaos and Nuesch-Germano, Melanie and Gkizeli, Konstantina and Bonaguro, Lorenzo and Reusch, Nico and Baßler, Kevin and Saridaki, Maria and Knoll, Rainer and Pecht, Tal and Kapellos, Theodore S and Doulou, Sarandia and Kröger, Charlotte and Herbert, Miriam and Holsten, Lisa and Horne, Arik and Gemünd, Ioanna D and Rovina, Nikoletta and Agrawal, Shobhit and Dahm, Kilian and van Uelft, Martina and Drews, Anna and Lenkeit, Lena and Bruse, Niklas and Gerretsen, Jelle and Gierlich, Jannik and Becker, Matthias and Händler, Kristian and Kraut, Michael and Theis, Heidi and Mengiste, Simachew and De Domenico, Elena and Schulte-Schrepping, Jonas and Seep, Lea and Raabe, Jan and Hoffmeister, Christoph and ToVinh, Michael and Keitel, Verena and Rieke, Gereon and Talevi, Valentina and Skowasch, Dirk and Aziz, N Ahmad and Pickkers, Peter and van de Veerdonk, Frank L and Netea, Mihai G and Schultze, Joachim L and Kox, Matthijs and Breteler, Monique M B and Nattermann, Jacob and Koutsoukou, Antonia and Giamarellos-Bourboulis, Evangelos J and Ulas, Thomas and De Domenico, Elena and Bonaguro, Lorenzo and Schulte-Schrepping, Jonas and Becker, Matthias and Händler, Kristian and Schultze, Joachim L and Bonaguro, Lorenzo and Köhne, Maren and Schmidleithner, Lisa and Schulte-Schrepping, Jonas and Warnat-Herresthal, Stefanie and Horne, Arik and Kern, Paul and Günther, Patrick and Ter Horst, Rob and Jaeger, Martin and Rahmouni, Souad and Georges, Michel and Falk, Christine S and Li, Yang and Mass, Elvira and Beyer, Marc and Joosten, Leo A B and Netea, Mihai G and Ulas, Thomas and Schultze, Joachim L and Aschenbrenner, Anna C and Schulte-Schrepping, Jonas and Reusch, Nico and Paclik, Daniela and Baßler, Kevin and Schlickeiser, Stephan and Zhang, Bowen and Krämer, Benjamin and Krammer, Tobias and Brumhard, Sophia and Bonaguro, Lorenzo and De Domenico, Elena and Wendisch, Daniel and Grasshoff, Martin and Kapellos, Theodore S and Beckstette, Michael and Pecht, Tal and Saglam, Adem and Dietrich, Oliver and Mei, Henrik E and Schulz, Axel R and Conrad, Claudia and Kunkel, Désirée and Vafadarnejad, Ehsan and Xu, Cheng-Jian and Horne, Arik and Herbert, Miriam and Drews, Anna and Thibeault, Charlotte and Pfeiffer, Moritz and Hippenstiel, Stefan and Hocke, Andreas and Müller-Redetzky, Holger and Heim, Katrin-Moira and Machleidt, Felix and Uhrig, Alexander and Bosquillon de Jarcy, Laure and Jürgens, Linda and Stegemann, Miriam and Glösenkamp, Christoph R and Volk, Hans-Dieter and Goffinet, Christine and Landthaler, Markus and Wyler, Emanuel and Georg, Philipp and Schneider, Maria and Dang-Heine, Chantip and Neuwinger, Nick and Kappert, Kai and Tauber, Rudolf and Corman, Victor and Raabe, Jan and Kaiser, Kim Melanie and Vinh, Michael To and Rieke, Gereon and Meisel, Christian and Ulas, Thomas and Becker, Matthias and Geffers, Robert and Witzenrath, Martin and Drosten, Christian and Suttorp, Norbert and von Kalle, Christof and Kurth, Florian and Händler, Kristian and Schultze, Joachim L and Aschenbrenner, Anna C and Li, Yang and Nattermann, Jacob and Sawitzki, Birgit and Saliba, Antoine-Emmanuel and Sander, Leif Erik and Kapellos, Theodore S and Bonaguro, Lorenzo and Gemünd, Ioanna and Reusch, Nico and Saglam, Adem and Hinkley, Emily R and Schultze, Joachim L",
    type = "Journal Article; Journal Article; Journal Article; Video-Audio Media; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Journal Article; Research Support, Non-U.S. Gov't; Review; Journal Article; Journal Article; Research Support, Non-U.S. Gov't; Review; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Review; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Journal Article; Research Support, Non-U.S. Gov't; Review",
    title = "Isogenic patient-derived organoids reveal early neurodevelopmental defects inspinal muscular atrophy initiation.; The life-saving benefit of dexamethasone in severe COVID-19 is linked to areversal of monocyte dysregulation.; Cost-Efficient Transcriptomic-Based Drug Screening.; Faecal microbial transfer and complex carbohydrates mediate protection againstCOPD.; Identification of drug candidates targeting monocyte reprogramming in peopleliving with HIV.; Chromatin accessibility profiling of targeted cell populations with laser capturemicrodissection coupled to ATAC-seq.; Identification of the novel FOXP3-dependent T(reg) cell transcription factorMEOX1 by high-dimensional analysis of human CD4(+) T cells.; Systemic alterations in neutrophils and their precursors in early-stage chronicobstructive pulmonary disease.; huva: A human variation analysis framework to predict gene perturbation frompopulation-scale multi-omics data.; Lung T cell response in COVID-19.; Human variation in population-wide gene expression data predicts geneperturbation phenotype.; A guide to systems-level immunomics.; Decoding mechanism of action and sensitivity to drug candidates from integratedtranscriptome and chromatin state.; Alveolar macrophages in early stage COPD show functional deviations withproperties of impaired immune activation.; Complement activation induces excessive T cell cytotoxicity in severe COVID-19.; Induction of Rosette-to-Lumen stage embryoids using reprogramming paradigms inESCs.; Early IFN-α signatures and persistent dysfunction are distinguishing features ofNK cells in severe COVID-19.; Creld2 function during unfolded protein response is essential for livermetabolism homeostasis.; Swarm Learning for decentralized and confidential clinical machine learning.; Neutrophils in COVID-19.; Creld1 regulates myocardial development and function.; Disease severity-specific neutrophil signatures in blood transcriptomes stratifyCOVID-19 patients.; Optimized workflow for single-cell transcriptomics on infectious diseasesincluding COVID-19.; CRELD1 modulates homeostasis of the immune system in mice and humans.; Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment.; Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases.",
    journal = "Cell reports. Medicine; Cell; Journal of visualized experiments : JoVE; Gut; Frontiers in immunology; Cell reports methods; Frontiers in immunology; Cell reports; STAR protocols; Frontiers in immunology; iScience; Nature immunology; eLife; Frontiers in immunology; Cell; Nature communications; Immunity; FASEB journal : official publication of the Federation of American Societies forExperimental Biology; Nature; Frontiers in immunology; Journal of molecular and cellular cardiology; Genome medicine; STAR protocols; Nature immunology; Cell; Frontiers in immunology",
    date = "2024 Aug 20; 2024 Aug 8; 2024 Feb 23; 2024 Apr 5; 2023; 2023 Oct 23; 2023; 2023 Jun 27; 2023 Mar 24; 2023; 2022 Nov 18; 2022 Oct; 2022 Aug 31; 2022; 2022 Feb 3; 2021 Dec 16; 2021 Nov 9; 2021 Oct; 2021 Jun; 2021; 2021 Jul; 2021 Jan 13; 2020 Dec 18; 2020 Dec; 2020 Sep 17; 2019",
    volume = "5; 187; 73; 14; 3; 14; 42; 4; 14; 25; 23; 11; 13; 185; 12; 54; 35; 594; 12; 156; 13; 1; 21; 182; 10",
    pages = "101659; 4318-4335.e20; 751-769; 1275136; 100598; 1107397; 112525; 102193; 1108716; 105328; 1412-1423; 917232; 493-512.e25; 7322; 2650-2669.e14; e21939; 265-270; 652470; 45-56; 7; 100233; 1517-1527; 1419-1440.e23; 2035",
    keywords = "isogenic SMA model | neurodevelopmental defects | neuromesodermal progenitors | organoids | spinal cord | COVID-19 | companion diagnostics | glucocorticoid | in vivo target engagement | monocytes | single-cell analysis | transcriptomics | treatment response prediction | BASIC SCIENCES | COLONIC MICROFLORA | DIETARY FIBRE | IMMUNOLOGY | INFLAMMATORY DISEASES | HIV | drug repurposing | inflammation | monocytes | systems immunology | transcriptomics | ATAC-seq | CP: Molecular biology | chromatin accessibility | epigenomics | laser capture microdissection | spatial omics | Foxp3 | MEOX1 | Treg cells | human CD4 | regulatory T cells | CP: Immunology | blood | bone marrow | chronic obstructive pulmonary disease | granulopoiesis | neutrophil | single-cell transcriptomics | Bioinformatics | Gene Expression | Immunology | RNAseq | Systems Biology | COVID-19 | SARS-CoV-2 | T-cell | lung | pathomechanism | Clinical genetics | Human genetics | Pathophysiology | chromatin accessibility | computational biology | drug candidate | human | mechanism of action | multi-omics | sensitivity ML prediction | systems biology | transcriptome | TGF-β1 | blood | bronchoalveolar lavage | chronic obstructive pulmonary disease | impaired immune activation | macrophage | monocyte | COVID-19 | T cells | complement | cytotoxicity | immunopathology | COVID-19 | NK cells | TNF | antiviral | lung fibrosis | moderate | proteomics | scRNA-seq | severe | type 1 IFN | Creld2 | ER stress | NASH | UPR | liver steatosis | COVID-19 | SARS-CoV-2 | clinical trials | granulocytes | neutrophils | scRNA-seq | viral infection | Creld1 | ECM | Heart development | Notch | Trabeculation | Blood transcriptomics | COVID-19 | Co-expression analysis | Drug repurposing | Granulocytes | Molecular disease phenotypes | Neutrophils | Stratification | Transcriptome | Antibody | Bioinformatics | Clinical protocol | Flow cytometry/mass cytometry | Gene expression | Immunology | Proteomics | RNA-seq | Sequence analysis | Sequencing | COVID-19 | SARS-CoV-2 | dysfunctional neutrophils | emergency myelopoiesis | immune profiling | mass cytometry | monocytes | neutrophils | scRNA-seq | atherosclerosis | diet | human monocytes | neurodegeneration | respiratory diseases",
    issn = "2666-3791 (Electronic); 2666-3791 (Linking); 1097-4172 (Electronic); 0092-8674 (Linking); 1940-087X (Electronic); 1940-087X (Linking); 1468-3288 (Electronic); 0017-5749 (Linking); 1664-3224 (Electronic); 1664-3224 (Linking); 2667-2375 (Electronic); 2667-2375 (Linking); 1664-3224 (Electronic); 1664-3224 (Linking); 2211-1247 (Electronic); 2666-1667 (Electronic); 2666-1667 (Linking); 1664-3224 (Electronic); 1664-3224 (Linking); 2589-0042 (Electronic); 2589-0042 (Linking); 1529-2916 (Electronic); 1529-2908 (Linking); 2050-084X (Electronic); 2050-084X (Linking); 1664-3224 (Electronic); 1664-3224 (Linking); 1097-4172 (Electronic); 0092-8674 (Print); 0092-8674 (Linking); 2041-1723 (Electronic); 2041-1723 (Linking); 1097-4180 (Electronic); 1074-7613 (Print); 1074-7613 (Linking); 1530-6860 (Electronic); 0892-6638 (Linking); 1476-4687 (Electronic); 0028-0836 (Print); 0028-0836 (Linking); 1664-3224 (Electronic); 1664-3224 (Linking); 1095-8584 (Electronic); 0022-2828 (Linking); 1756-994X (Electronic); 1756-994X (Linking); 2666-1667 (Electronic); 2666-1667 (Linking); 1529-2916 (Electronic); 1529-2908 (Linking); 1097-4172 (Electronic); 0092-8674 (Print); 0092-8674 (Linking); 1664-3224 (Electronic); 1664-3224 (Linking)",
    abstract = {Whether neurodevelopmental defects underlie postnatal neuronal death inneurodegeneration is an intriguing hypothesis only recently explored. Here, wefocus on spinal muscular atrophy (SMA), a neuromuscular disorder caused byreduced survival of motor neuron (SMN) protein levels leading to spinal motorneuron (MN) loss and muscle wasting. Using the first isogenic patient-derivedinduced pluripotent stem cell (iPSC) model and a spinal cord organoid (SCO)system, we show that SMA SCOs exhibit abnormal morphological development, reducedexpression of early neural progenitor markers, and accelerated expression of MNprogenitor and MN markers. Longitudinal single-cell RNA sequencing reveals markeddefects in neural stem cell specification and fewer MNs, favoring mesodermalprogenitors and muscle cells, a bias also seen in early SMA mouse embryos.Surprisingly, SMN2-to-SMN1 conversion does not fully reverse these developmentalabnormalities. These suggest that early neurodevelopmental defects may underlielater MN degeneration, indicating that postnatal SMN-increasing interventionsmight not completely amend SMA pathology in all patients.; Dexamethasone is a life-saving treatment for severe COVID-19, yet its mechanismof action is unknown, and many patients deteriorate or die despite timelytreatment initiation. Here, we identify dexamethasone treatment-induced cellularand molecular changes associated with improved survival in COVID-19 patients. Weobserved a reversal of transcriptional hallmark signatures in monocytesassociated with severe COVID-19 and the induction of a monocyte substatecharacterized by the expression of glucocorticoid-response genes. These molecularresponses to dexamethasone were detected in circulating and pulmonary monocytes,and they were directly linked to survival. Monocyte single-cell RNA sequencing(scRNA-seq)-derived signatures were enriched in whole blood transcriptomes ofpatients with fatal outcome in two independent cohorts, highlighting thepotential for identifying non-responders refractory to dexamethasone. Ourfindings link the effects of dexamethasone to specific immunomodulation andreversal of monocyte dysregulation, and they highlight the potential ofsingle-cell omics for monitoring in vivo target engagement of immunomodulatorydrugs and for patient stratification for precision medicine approaches.; Transcriptomics allows to obtain comprehensive insights into cellular programsand their responses to perturbations. Despite a significant decrease in the costsof library production and sequencing in the last decade, applying thesetechnologies at the scale necessary for drug screening remains prohibitivelyexpensive, obstructing the immense potential of these methods. Our study presentsa cost-effective system for transcriptome-based drug screening, combiningminiaturized perturbation cultures with mini-bulk transcriptomics. The optimizedmini-bulk protocol provides informative biological signals at cost-effectivesequencing depth, enabling extensive screening of known drugs and new molecules.Depending on the chosen treatment and incubation time, this protocol will resultin sequencing libraries within approximately 2 days. Due to several stoppingpoints within this protocol, the library preparation, as well as the sequencing,can be performed time-independently. Processing simultaneously a high number ofsamples is possible; measurement of up to 384 samples was tested without loss ofdata quality. There are also no known limitations to the number of conditionsand/or drugs, despite considering variability in optimal drug incubation times.; OBJECTIVE: Chronic obstructive pulmonary disease (COPD) is a major cause ofglobal illness and death, most commonly caused by cigarette smoke. The mechanismsof pathogenesis remain poorly understood, limiting the development of effectivetherapies. The gastrointestinal microbiome has been implicated in chronic lungdiseases via the gut-lung axis, but its role is unclear. DESIGN: Using an in vivomouse model of cigarette smoke (CS)-induced COPD and faecal microbial transfer(FMT), we characterised the faecal microbiota using metagenomics, proteomics andmetabolomics. Findings were correlated with airway and systemic inflammation,lung and gut histopathology and lung function. Complex carbohydrates wereassessed in mice using a high resistant starch diet, and in 16 patients with COPDusing a randomised, double-blind, placebo-controlled pilot study of inulinsupplementation. RESULTS: FMT alleviated hallmark features of COPD (inflammation,alveolar destruction, impaired lung function), gastrointestinal pathology andsystemic immune changes. Protective effects were additive to smoking cessation,and transfer of CS-associated microbiota after antibiotic-induced microbiomedepletion was sufficient to increase lung inflammation while suppressing colonicimmunity in the absence of CS exposure. Disease features correlated with therelative abundance of Muribaculaceae, Desulfovibrionaceae and Lachnospiraceaefamily members. Proteomics and metabolomics identified downregulation of glucoseand starch metabolism in CS-associated microbiota, and supplementation of mice orhuman patients with complex carbohydrates improved disease outcomes. CONCLUSION:The gut microbiome contributes to COPD pathogenesis and can be targetedtherapeutically.; INTRODUCTION: People living with HIV (PLHIV) are characterized by functionalreprogramming of innate immune cells even after long-term antiretroviral therapy(ART). In order to assess technical feasibility of omics technologies forapplication to larger cohorts, we compared multiple omics data layers. METHODS:Bulk and single-cell transcriptomics, flow cytometry, proteomics, chromatinlandscape analysis by ATAC-seq as well as ex vivo drug stimulation were performedin a small number of blood samples derived from PLHIV and healthy controls fromthe 200-HIV cohort study. RESULTS: Single-cell RNA-seq analysis revealed thatmost immune cells in peripheral blood of PLHIV are altered in theirtranscriptomes and that a specific functional monocyte state previously describedin acute HIV infection is still existing in PLHIV while other monocyte cellstates are only occurring acute infection. Further, a reverse transcriptomeapproach on a rather small number of PLHIV was sufficient to identify drugcandidates for reversing the transcriptional phenotype of monocytes in PLHIV.DISCUSSION: These scientific findings and technological advancements for clinicalapplication of single-cell transcriptomics form the basis for the larger 2000-HIVmulticenter cohort study on PLHIV, for which a combination of bulk andsingle-cell transcriptomics will be included as the leading technology todetermine disease endotypes in PLHIV and to predict disease trajectories andoutcomes.; Spatially resolved omics technologies reveal context-dependent cellularregulatory networks in tissues of interest. Beyond transcriptome analysis,information on epigenetic traits and chromatin accessibility can provide furtherinsights on gene regulation in health and disease. Nevertheless, compared to theenormous advancements in spatial transcriptomics technologies, the field ofspatial epigenomics is much younger and still underexplored. In this study, wereport laser capture microdissection coupled to ATAC-seq (LCM-ATAC-seq) appliedto fresh frozen samples for the spatial characterization of chromatinaccessibility. We first demonstrate the efficient use of LCM coupled to in situtagmentation and evaluate its performance as a function of cell number,microdissected areas, and tissue type. Further, we demonstrate its use for thetargeted chromatin accessibility analysis of discrete contiguous or scatteredcell populations in tissues via single-nuclei capture based on immunostaining forspecific cellular markers.; CD4(+) T cells play a central role in the adaptive immune response through theircapacity to activate, support and control other immune cells. Although thesecells have become the focus of intense research, a comprehensive understanding ofthe underlying regulatory networks that orchestrate CD4(+) T cell function andactivation is still incomplete. Here, we analyzed a large transcriptomic datasetconsisting of 48 different human CD4(+) T cell conditions. By performing reversenetwork engineering, we identified six common denominators of CD4(+) T cellfunctionality (CREB1, E2F3, AHR, STAT1, NFAT5 and NFATC3). Moreover, we alsoanalyzed condition-specific genes which led us to the identification of thetranscription factor MEOX1 in T(reg) cells. Expression of MEOX1 was comparable toFOXP3 in T(reg) cells and can be upregulated by IL-2. Epigenetic analysesrevealed a permissive epigenetic landscape for MEOX1 solely in T(reg) cells.Knockdown of MEOX1 in T(reg) cells revealed a profound impact on downstream geneexpression programs and T(reg) cell suppressive capacity. These findings in thecontext of CD4(+) T cells contribute to a better understanding of thetranscriptional networks and biological mechanisms controlling CD4(+) T cellfunctionality, which opens new avenues for future therapeutic strategies.; Systemic inflammation is established as part of late-stage severe lung disease,but molecular, functional, and phenotypic changes in peripheral immune cells inearly disease stages remain ill defined. Chronic obstructive pulmonary disease(COPD) is a major respiratory disease characterized by small-airway inflammation,emphysema, and severe breathing difficulties. Using single-cell analyses wedemonstrate that blood neutrophils are already increased in early-stage COPD, andchanges in molecular and functional neutrophil states correlate with lungfunction decline. Assessing neutrophils and their bone marrow precursors in amurine cigarette smoke exposure model identified similar molecular changes inblood neutrophils and precursor populations that also occur in the blood andlung. Our study shows that systemic molecular alterations in neutrophils andtheir precursors are part of early-stage COPD, a finding to be further exploredfor potential therapeutic targets and biomarkers for early diagnosis and patientstratification.; Variance of gene expression is intrinsic to any given natural population. Here,we present a protocol to analyze this variance using a conditional quasi loss-and gain-of-function approach. The huva (human variation) package takes advantageof population-scale multi-omics data to infer gene function and the relationshipbetween phenotype and gene expression. We describe the steps for setting up thehuva workspace, formatting datasets, performing huva experiments, and exportingdata. For complete details on the use and execution of this protocol, pleaserefer to Bonaguro et al. (2022).(1).; The COVID-19 pandemic has shown the potentially devastating impact of novelrespiratory infections worldwide. Insightful data obtained in the last years haveshed light on the pathophysiology of SARS-CoV-2 infection and the role of theinflammatory response in driving both the resolution of the disease anduncontrolled deleterious inflammatory status in severe cases. In thismini-review, we cover some important aspects of the role of T cells in COVID-19with a special focus on the local response in the lung. We focus on the reportedT cell phenotypes in mild, moderate, and severe COVID-19, focusing on lunginflammation and on both the protective and damaging roles of the T cellresponse, also highlighting the open questions in the field.; Population-scale datasets of healthy individuals capture genetic andenvironmental factors influencing gene expression. The expression variance of agene of interest (GOI) can be exploited to set up a quasi loss- orgain-of-function "in population" experiment. We describe here an approach, huva(human variation), taking advantage of population-scale multi-layered data toinfer gene function and relationships between phenotypes and expression. Within areference dataset, huva derives two experimental groups with LOW or HIGHexpression of the GOI, enabling the subsequent comparison of theirtranscriptional profile and functional parameters. We demonstrate that thisapproach robustly identifies the phenotypic relevance of a GOI allowing thestratification of genes according to biological functions, and we generalize thisconcept to almost 16,000 genes in the human transcriptome. Additionally, wedescribe how huva predicts monocytes to be the major cell type in thepathophysiology of STAT1 mutations, evidence validated in a clinical cohort.; The immune system is highly complex and distributed throughout an organism, withhundreds to thousands of cell states existing in parallel with diverse molecularpathways interacting in a highly dynamic and coordinated fashion. Although thecharacterization of individual genes and molecules is of the utmost importancefor understanding immune-system function, high-throughput, high-resolution omicstechnologies combined with sophisticated computational modeling andmachine-learning approaches are creating opportunities to complement standardimmunological methods with new insights into immune-system dynamics. Like systemsimmunology itself, immunology researchers must take advantage of thesetechnologies and form their own diverse networks, connecting with researchersfrom other disciplines. This Review is an introduction and 'how-to guide' forimmunologists with no particular experience in the field of omics but with theintention to learn about and apply these systems-level approaches, and forimmunologists who want to make the most of interdisciplinary networks.; Omics-based technologies are driving major advances in precision medicine, butefforts are still required to consolidate their use in drug discovery. In thiswork, we exemplify the use of multi-omics to support the development of3-chloropiperidines, a new class of candidate anticancer agents. Combinedanalyses of transcriptome and chromatin accessibility elucidated the mechanismsunderlying sensitivity to test agents. Furthermore, we implemented a newversatile strategy for the integration of RNA- and ATAC-seq (Assay forTransposase-Accessible Chromatin) data, able to accelerate and extend thestandalone analyses of distinct omic layers. This platform guided theconstruction of a perturbation-informed basal signature predicting cancer celllines' sensitivity and to further direct compound development against specifictumor types. Overall, this approach offers a scalable pipeline to support theearly phases of drug discovery, understanding of mechanisms, and potentiallyinform the positioning of therapeutics in the clinic.; Despite its high prevalence, the cellular and molecular mechanisms of chronicobstructive pulmonary disease (COPD) are far from being understood. Here, wedetermine disease-related changes in cellular and molecular compositions withinthe alveolar space and peripheral blood of a cohort of COPD patients andcontrols. Myeloid cells were the largest cellular compartment in the alveolarspace with invading monocytes and proliferating macrophages elevated in COPD.Modeling cell-to-cell communication, signaling pathway usage, and transcriptionfactor binding predicts TGF-β1 to be a major upstream regulator oftranscriptional changes in alveolar macrophages of COPD patients. Functionally,macrophages in COPD showed reduced antigen presentation capacity, accumulation ofcholesteryl ester, reduced cellular chemotaxis, and mitochondrial dysfunction,reminiscent of impaired immune activation.; Severe COVID-19 is linked to both dysfunctional immune response and unrestrainedimmunopathology, and it remains unclear whether T cells contribute to diseasepathology. Here, we combined single-cell transcriptomics and single-cellproteomics with mechanistic studies to assess pathogenic T cell functions andinducing signals. We identified highly activated CD16(+) T cells with increasedcytotoxic functions in severe COVID-19. CD16 expression enabledimmune-complex-mediated, T cell receptor-independent degranulation andcytotoxicity not found in other diseases. CD16(+) T cells from COVID-19 patientspromoted microvascular endothelial cell injury and release of neutrophil andmonocyte chemoattractants. CD16(+) T cell clones persisted beyond acute diseasemaintaining their cytotoxic phenotype. Increased generation of C3a in severeCOVID-19 induced activated CD16(+) cytotoxic T cells. Proportions of activatedCD16(+) T cells and plasma levels of complement proteins upstream of C3a wereassociated with fatal outcome of COVID-19, supporting a pathological role ofexacerbated cytotoxicity and complement activation in COVID-19.; Blastocyst-derived stem cell lines were shown to self-organize into embryo-likestructures in 3D cell culture environments. Here, we provide evidence thatembryo-like structures can be generated solely based on transcriptionfactor-mediated reprogramming of embryonic stem cells in a simple 3D co-culturesystem. Embryonic stem cells in these cultures self-organize into elongated,compartmentalized embryo-like structures reflecting aspects of the inner regionsof the early post-implantation embryo. Single-cell RNA-sequencing revealstranscriptional profiles resembling epiblast, primitive-/visceral endoderm, andextraembryonic ectoderm of early murine embryos around E4.5-E5.5. In this stemcell-based embryo model, progression from rosette formation to lumenogenesisaccompanied by progression from naïve- to primed pluripotency was observed withinEpi-like cells. Additionally, lineage specification of primordial germ cells anddistal/anterior visceral endoderm-like cells was observed in epiblast- orvisceral endoderm-like compartments, respectively. The system presented in thisstudy allows for fast and reproducible generation of embryo-like structures,providing an additional tool to study aspects of early embryogenesis.; Longitudinal analyses of the innate immune system, including the earliest timepoints, are essential to understand the immunopathogenesis and clinical course ofcoronavirus disease (COVID-19). Here, we performed a detailed characterization ofnatural killer (NK) cells in 205 patients (403 samples; days 2 to 41 aftersymptom onset) from four independent cohorts using single-cell transcriptomicsand proteomics together with functional studies. We found elevated interferon(IFN)-α plasma levels in early severe COVD-19 alongside increased NK cellexpression of IFN-stimulated genes (ISGs) and genes involved in IFN-α signaling,while upregulation of tumor necrosis factor (TNF)-induced genes was observed inmoderate diseases. NK cells exert anti-SARS-CoV-2 (severe acute respiratorysyndrome coronavirus 2) activity but are functionally impaired in severeCOVID-19. Further, NK cell dysfunction may be relevant for the development offibrotic lung disease in severe COVID-19, as NK cells exhibited impairedanti-fibrotic activity. Our study indicates preferential IFN-α and TNF responsesin severe and moderate COVID-19, respectively, and associates a prolonged; The unfolded protein response (UPR) is associated with hepatic metabolicfunction, yet it is not well understood how endoplasmic reticulum (ER)disturbance might influence metabolic homeostasis. Here, we describe thephysiological function of Cysteine-rich with EGF-like domains 2 (Creld2),previously characterized as a downstream target of the ER-stress signaltransducer Atf6. To this end, we generated Creld2-deficient mice and induced UPRby injection of tunicamycin. Creld2 augments protein folding and creates aninterlink between the UPR axes through its interaction with proteins involved inthe cellular stress response. Thereby, Creld2 promotes tolerance to ER stress andrecovery from acute stress. Creld2-deficiency leads to a dysregulated UPR andcauses the development of hepatic steatosis during ER stress conditions.Moreover, Creld2-dependent enhancement of the UPR assists in the regulation ofenergy expenditure. Furthermore, we observed a sex dimorphism in human and mouselivers with only male patients showing an accumulation of CRELD2 protein duringthe progression from non-alcoholic fatty liver disease to non-alcoholicsteatohepatitis and only male Creld2-deficient mice developing hepatic steatosisupon aging. These results reveal a Creld2 function at the intersection betweenUPR and metabolic homeostasis and suggest a mechanism in which chronic ER stressunderlies fatty liver disease in males.; Fast and reliable detection of patients with severe and heterogeneous illnessesis a major goal of precision medicine(1,2). Patients with leukaemia can beidentified using machine learning on the basis of their blood transcriptomes(3).However, there is an increasing divide between what is technically possible andwhat is allowed, because of privacy legislation(4,5). Here, to facilitate theintegration of any medical data from any data owner worldwide without violatingprivacy laws, we introduce Swarm Learning-a decentralized machine-learningapproach that unites edge computing, blockchain-based peer-to-peer networking andcoordination while maintaining confidentiality without the need for a centralcoordinator, thereby going beyond federated learning. To illustrate thefeasibility of using Swarm Learning to develop disease classifiers usingdistributed data, we chose four use cases of heterogeneous diseases (COVID-19,tuberculosis, leukaemia and lung pathologies). With more than 16,400 bloodtranscriptomes derived from 127 clinical studies with non-uniform distributionsof cases and controls and substantial study biases, as well as more than 95,000chest X-ray images, we show that Swarm Learning classifiers outperform thosedeveloped at individual sites. In addition, Swarm Learning completely fulfilslocal confidentiality regulations by design. We believe that this approach willnotably accelerate the introduction of precision medicine.; Strong evidence has been accumulated since the beginning of the COVID-19 pandemicthat neutrophils play an important role in the pathophysiology, particularly inthose with severe disease courses. While originally considered to be a ratherhomogeneous cell type, recent attention to neutrophils has uncovered theirfascinating transcriptional and functional diversity as well as theirdevelopmental trajectories. These new findings are important to better understandthe many facets of neutrophil involvement not only in COVID-19 but also manyother acute or chronic inflammatory diseases, both communicable andnon-communicable. Here, we highlight the observed immune deviation of neutrophilsin COVID-19 and summarize several promising therapeutic attempts to preciselytarget neutrophils and their reactivity in patients with COVID-19.; CRELD1 (Cysteine-Rich with EGF-Like Domains 1) is a risk gene for non-syndromicatrioventricular septal defects in human patients. In a mouse model, Creld1 hasbeen shown to be essential for heart development, particularly in septum andvalve formation. However, due to the embryonic lethality of global Creld1knockout (KO) mice, its cell type-specific function during peri- and postnatalstages remains unknown. Here, we generated conditional Creld1 KO mice lackingCreld1 either in the endocardium (KO(Tie2)) or the myocardium (KO(MyHC)). Using acombination of cardiac phenotyping, histology, immunohistochemistry,; BACKGROUND: The SARS-CoV-2 pandemic is currently leading to increasing numbers ofCOVID-19 patients all over the world. Clinical presentations range fromasymptomatic, mild respiratory tract infection, to severe cases with acuterespiratory distress syndrome, respiratory failure, and death. Reports on adysregulated immune system in the severe cases call for a better characterizationand understanding of the changes in the immune system. METHODS: In order todissect COVID-19-driven immune host responses, we performed RNA-seq of wholeblood cell transcriptomes and granulocyte preparations from mild and severeCOVID-19 patients and analyzed the data using a combination of conventional anddata-driven co-expression analysis. Additionally, publicly available data wasused to show the distinction from COVID-19 to other diseases. Reverse drug targetprediction was used to identify known or novel drug candidates based on findingfrom data-driven findings. RESULTS: Here, we profiled whole blood transcriptomesof 39 COVID-19 patients and 10 control donors enabling a data-drivenstratification based on molecular phenotype. Neutrophil activation-associatedsignatures were prominently enriched in severe patient groups, which wascorroborated in whole blood transcriptomes from an independent second cohort of30 as well as in granulocyte samples from a third cohort of 16 COVID-19 patients(44 samples). Comparison of COVID-19 blood transcriptomes with those of acollection of over 3100 samples derived from 12 different viral infections,inflammatory diseases, and independent control samples revealed highly specifictranscriptome signatures for COVID-19. Further, stratified transcriptomespredicted patient subgroup-specific drug candidates targeting the dysregulatedsystemic immune response of the host. CONCLUSIONS: Our study provides novelinsights in the distinct molecular subgroups or phenotypes that are not simplyexplained by clinical parameters. We show that whole blood transcriptomes areextremely informative for COVID-19 since they capture granulocytes which aremajor drivers of disease severity.; In December 2019, a new coronavirus, SARS-CoV-2, which causes the respiratoryillness that led to the COVID-19 pandemic, was reported. In the face of such anew pathogen, special precautions must be taken to examine potentially infectiousmaterials due to the lack of knowledge on disease transmissibility, infectivity,and molecular pathogenicity. Here, we present a complete and safe workflow forperforming scRNA-seq experiments on blood samples of infected patients from cellisolation to data analysis using the micro-well based BD Rhapsody platform. Forcomplete information on the use and execution of this protocol, please refer toSchulte-Schrepping et al. (2020).; CRELD1 is a pivotal factor for heart development, the function of which isunknown in adult life. We here provide evidence that CRELD1 is an importantgatekeeper of immune system homeostasis. Exploiting expression variance in largehuman cohorts contrasting individuals with the lowest and highest CRELD1expression levels revealed strong phenotypic, functional and transcriptionaldifferences, including reduced CD4(+) T cell numbers. These findings werevalidated in T cell-specific Creld1-deficient mice. Loss of Creld1 was associatedwith simultaneous overactivation and increased apoptosis, resulting in a net lossof T cells with age. Creld1 was transcriptionally and functionally linked to Wntsignaling. Collectively, gene expression variance in large human cohorts combinedwith murine genetic models, transcriptomics and functional testing defines CRELD1as an important modulator of immune homeostasis.; Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tractinfection, however, a subset of patients progress to severe disease andrespiratory failure. The mechanism of protective immunity in mild forms and thepathogenesis of severe COVID-19 associated with increased neutrophil counts anddysregulated immune responses remain unclear. In a dual-center, two-cohort study,we combined single-cell RNA-sequencing and single-cell proteomics of whole-bloodand peripheral-blood mononuclear cells to determine changes in immune cellcomposition and activation in mild versus severe COVID-19 (242 samples from 109individuals) over time. HLA-DR(hi)CD11c(hi) inflammatory monocytes with aninterferon-stimulated gene signature were elevated in mild COVID-19. SevereCOVID-19 was marked by occurrence of neutrophil precursors, as evidence ofemergency myelopoiesis, dysfunctional mature neutrophils, and HLA-DR(lo)monocytes. Our study provides detailed insights into the systemic immune responseto SARS-CoV-2 infection and reveals profound alterations in the myeloid cellcompartment associated with severe COVID-19.; Human monocytes are divided in three major populations; classical(CD14(+)CD16(-)), non-classical (CD14(dim)CD16(+)), and intermediate(CD14(+)CD16(+)). Each of these subsets is distinguished from each other by theexpression of distinct surface markers and by their functions in homeostasis anddisease. In this review, we discuss the most up-to-date phenotypic classificationof human monocytes that has been greatly aided by the application of novelsingle-cell transcriptomic and mass cytometry technologies. Furthermore, we shedlight on the role of these plastic immune cells in already recognized andemerging human chronic diseases, such as obesity, atherosclerosis, chronicobstructive pulmonary disease, lung fibrosis, lung cancer, and Alzheimer'sdisease. Our aim is to provide an insight into the contribution of humanmonocytes to the progression of these diseases and highlight their candidacy aspotential therapeutic cell targets.},
    year = "2024",
    doi = "10.3389/fimmu.2019.02035",
    pmid = "39067446; 38964327; 38465925; 38331563; 38077315; 37776856; 37559728; 37243592; 36964906; 36875071; 36310583; 36138185; 36043458; 35979364; 35032429; 34916498; 34592166; 34549824; 34040261; 33841435; 33773996; 33441124; 33377120; 33169013; 32810438; 31543877",
    own = "NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM; NLM",
    stat = "MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; Publisher; MEDLINE; PubMed-not-MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE; MEDLINE",
    dcom = "20240821; 20240809; 20240312; 20240408; 20240109; 20231030; 20230811; 20231004; 20230308; 20221012; 20220902; 20220819; 20220210; 20220106; 20211123; 20211027; 20210617; 20210419; 20220110; 20210121; 20220217; 20210215; 20201001; 20200929",
    lr = "20240912; 20240809; 20240312; 20240805; 20240325; 20241007; 20230814; 20240401; 20230331; 20240913; 20240320; 20230202; 20240320; 20240902; 20240214; 20230210; 20240909; 20211027; 20210803; 20210419; 20240226; 20240805; 20220217; 20210702; 20231111; 20200929",
    ip = "8; 16; 204; 5; 10; 6; 2; 11; 10; 3; 1; 11; 10; 7862; 1; 3; 12; 6",
    lid = "S2666-3791(24)00373-2 [pii]; 10.1016/j.xcrm.2024.101659 [doi]; 101659; S0092-8674(24)00654-8 [pii]; 10.1016/j.cell.2024.06.014 [doi]; 10.3791/65930 [doi]; 10.1136/gutjnl-2023-330521 [doi]; 10.3389/fimmu.2023.1275136 [doi]; 1275136; S2667-2375(23)00250-3 [pii]; 10.1016/j.crmeth.2023.100598 [doi]; 100598; 10.3389/fimmu.2023.1107397 [doi]; 1107397; S2211-1247(23)00536-3 [pii]; 10.1016/j.celrep.2023.112525 [doi]; 112525; S2666-1667(23)00151-X [pii]; 10.1016/j.xpro.2023.102193 [doi]; 102193; 10.3389/fimmu.2023.1108716 [doi]; 1108716; 10.1016/j.isci.2022.105328 [doi]; 105328; 10.1038/s41590-022-01309-9 [doi]; 10.7554/eLife.78012 [doi]; e78012; 10.3389/fimmu.2022.917232 [doi]; 917232; S0092-8674(21)01562-2 [pii]; 10.1016/j.cell.2021.12.040 [doi]; 10.1038/s41467-021-27586-w [doi]; 7322; S1074-7613(21)00365-4 [pii]; 10.1016/j.immuni.2021.09.002 [doi]; 10.1096/fj.202002713RR [doi]; 10.1038/s41586-021-03583-3 [doi]; 10.3389/fimmu.2021.652470 [doi]; 652470; S0022-2828(21)00065-1 [pii]; 10.1016/j.yjmcc.2021.03.008 [doi]; 10.1186/s13073-020-00823-5 [doi]; 7; 10.1016/j.xpro.2020.100233 [doi]; 100233; 10.1038/s41590-020-00811-2 [doi]; S0092-8674(20)30992-2 [pii]; 10.1016/j.cell.2020.08.001 [doi]; 10.3389/fimmu.2019.02035 [doi]; 2035",
    ci = "Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.; Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.; © Author(s) (or their employer(s)) 2024. No commercial re-use. See rights andpermissions. Published by BMJ.; Copyright © 2023 Knoll, Bonaguro, dos Santos, Warnat-Herresthal, Jacobs-Cleophas,Blümel, Reusch, Horne, Herbert, Nuesch-Germano, Otten, van der Heijden, van deWijer, Shalek, Händler, Becker, Beyer, Netea, Joosten, van der Ven, Schultze andAschenbrenner.; Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.; Copyright © 2023 Baßler, Schmidleithner, Shakiba, Elmzzahi, Köhne, Floess,Scholz, Ohkura, Sadlon, Klee, Neubauer, Sakaguchi, Barry, Huehn, Bonaguro, Ulasand Beyer.; Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.; Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.; Copyright © 2023 Shakiba, Gemünd, Beyer and Bonaguro.; © 2022 The Authors.; © 2022. Springer Nature America, Inc.; © 2022, Carraro et al.; Copyright © 2022 Baßler, Fujii, Kapellos, Dudkin, Reusch, Horne, Reiz, Luecken,Osei-Sarpong, Warnat-Herresthal, Bonaguro, Schulte-Schrepping, Wagner, Günther,Pizarro, Schreiber, Knoll, Holsten, Kröger, De Domenico, Becker, Händler,Wohnhaas, Baumgartner, Köhler, Theis, Kraut, Wadsworth, Hughes, Ferreira,Hinkley, Kaltheuner, Geyer, Thiele, Shalek, Feißt, Thomas, Dickten, Beyer, Baum,Yosef, Aschenbrenner, Ulas, Hasenauer, Theis, Skowasch and Schultze.; Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.; © 2021. The Author(s).; Copyright © 2021 Elsevier Inc. All rights reserved.; © 2021 The Authors. The FASEB Journal published by Wiley Periodicals LLC onbehalf of Federation of American Societies for Experimental Biology.; Copyright © 2021 Reusch, De Domenico, Bonaguro, Schulte-Schrepping, Baßler,Schultze and Aschenbrenner.; Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.; © 2020 The Author(s).; Copyright © 2020 Elsevier Inc. All rights reserved.",
    au = "Grass T; Dokuzluoglu Z; Buchner F; Rosignol I; Thomas J; Caldarelli A; Dalinskaya A; Becker J; Rost F; Marass M; Wirth B; Beyer M; Bonaguro L; Rodriguez-Muela N; Knoll R; Helbig ET; Dahm K; Bolaji O; Hamm F; Dietrich O; van Uelft M; Müller S; Bonaguro L; Schulte-Schrepping J; Petrov L; Krämer B; Kraut M; Stubbemann P; Thibeault C; Brumhard S; Theis H; Hack G; De Domenico E; Nattermann J; Becker M; Beyer MD; Hillus D; Georg P; Loers C; Tiedemann J; Tober-Lau P; Lippert L; Millet Pascual-Leone B; Tacke F; Rohde G; Suttorp N; Witzenrath M; Saliba AE; Ulas T; Polansky JK; Sawitzki B; Sander LE; Schultze JL; Aschenbrenner AC; Kurth F; Leidner J; Theis H; Kraut M; Ragogna A; Beyer M; Schultze J; Schulte-Schrepping J; Carraro C; Bonaguro L; Budden KF; Shukla SD; Bowerman KL; Vaughan A; Gellatly SL; Wood DLA; Lachner N; Idrees S; Rehman SF; Faiz A; Patel VK; Donovan C; Alemao CA; Shen S; Amorim N; Majumder R; Vanka KS; Mason J; Haw TJ; Tillet B; Fricker M; Keely S; Hansbro N; Belz GT; Horvat J; Ashhurst T; van Vreden C; McGuire H; Fazekas de St Groth B; King NJC; Crossett B; Cordwell SJ; Bonaguro L; Schultze JL; Hamilton-Williams EE; Mann E; Forster SC; Cooper MA; Segal LN; Chotirmall SH; Collins P; Bowman R; Fong KM; Yang IA; Wark PAB; Dennis PG; Hugenholtz P; Hansbro PM; Knoll R; Bonaguro L; Dos Santos JC; Warnat-Herresthal S; Jacobs-Cleophas MCP; Blümel E; Reusch N; Horne A; Herbert M; Nuesch-Germano M; Otten T; van der Heijden WA; van de Wijer L; Shalek AK; Händler K; Becker M; Beyer MD; Netea MG; Joosten LAB; van der Ven AJAM; Schultze JL; Aschenbrenner AC; Carraro C; Bonaguro L; Srinivasa R; van Uelft M; Isakzai V; Schulte-Schrepping J; Gambhir P; Elmzzahi T; Montgomery JV; Hayer H; Li Y; Theis H; Kraut M; Mahbubani KT; Aschenbrenner AC; König I; Fava E; Fried HU; De Domenico E; Beyer M; Saglam A; Schultze JL; Baßler K; Schmidleithner L; Shakiba MH; Elmzzahi T; Köhne M; Floess S; Scholz R; Ohkura N; Sadlon T; Klee K; Neubauer A; Sakaguchi S; Barry SC; Huehn J; Bonaguro L; Ulas T; Beyer M; Kapellos TS; Baßler K; Fujii W; Nalkurthi C; Schaar AC; Bonaguro L; Pecht T; Galvao I; Agrawal S; Saglam A; Dudkin E; Frishberg A; de Domenico E; Horne A; Donovan C; Kim RY; Gallego-Ortega D; Gillett TE; Ansari M; Schulte-Schrepping J; Offermann N; Antignano I; Sivri B; Lu W; Eapen MS; van Uelft M; Osei-Sarpong C; van den Berge M; Donker HC; Groen HJM; Sohal SS; Klein J; Schreiber T; Feißt A; Yildirim AÖ; Schiller HB; Nawijn MC; Becker M; Händler K; Beyer M; Capasso M; Ulas T; Hasenauer J; Pizarro C; Theis FJ; Hansbro PM; Skowasch D; Schultze JL; Aschenbrenner AC; Bonaguro L; Shakiba MH; Gemünd I; Beyer M; Bonaguro L; Bonaguro L; Schulte-Schrepping J; Carraro C; Sun LL; Reiz B; Gemünd I; Saglam A; Rahmouni S; Georges M; Arts P; Hoischen A; Joosten LAB; van de Veerdonk FL; Netea MG; Händler K; Mukherjee S; Ulas T; Schultze JL; Aschenbrenner AC; Bonaguro L; Schulte-Schrepping J; Ulas T; Aschenbrenner AC; Beyer M; Schultze JL; Carraro C; Bonaguro L; Schulte-Schrepping J; Horne A; Oestreich M; Warnat-Herresthal S; Helbing T; De Franco M; Haendler K; Mukherjee S; Ulas T; Gandin V; Goettlich R; Aschenbrenner AC; Schultze JL; Gatto B; Baßler K; Fujii W; Kapellos TS; Dudkin E; Reusch N; Horne A; Reiz B; Luecken MD; Osei-Sarpong C; Warnat-Herresthal S; Bonaguro L; Schulte-Schrepping J; Wagner A; Günther P; Pizarro C; Schreiber T; Knoll R; Holsten L; Kröger C; De Domenico E; Becker M; Händler K; Wohnhaas CT; Baumgartner F; Köhler M; Theis H; Kraut M; Wadsworth MH 2nd; Hughes TK; Ferreira HJ; Hinkley E; Kaltheuner IH; Geyer M; Thiele C; Shalek AK; Feißt A; Thomas D; Dickten H; Beyer M; Baum P; Yosef N; Aschenbrenner AC; Ulas T; Hasenauer J; Theis FJ; Skowasch D; Schultze JL; Georg P; Astaburuaga-García R; Bonaguro L; Brumhard S; Michalick L; Lippert LJ; Kostevc T; Gäbel C; Schneider M; Streitz M; Demichev V; Gemünd I; Barone M; Tober-Lau P; Helbig ET; Hillus D; Petrov L; Stein J; Dey HP; Paclik D; Iwert C; Mülleder M; Aulakh SK; Djudjaj S; Bülow RD; Mei HE; Schulz AR; Thiel A; Hippenstiel S; Saliba AE; Eils R; Lehmann I; Mall MA; Stricker S; Röhmel J; Corman VM; Beule D; Wyler E; Landthaler M; Obermayer B; von Stillfried S; Boor P; Demir M; Wesselmann H; Suttorp N; Uhrig A; Müller-Redetzky H; Nattermann J; Kuebler WM; Meisel C; Ralser M; Schultze JL; Aschenbrenner AC; Thibeault C; Kurth F; Sander LE; Blüthgen N; Sawitzki B; Langkabel J; Horne A; Bonaguro L; Holsten L; Hesse T; Knaus A; Riedel Y; Becker M; Händler K; Elmzzahi T; Bassler K; Reusch N; Yeghiazarian LH; Pecht T; Saglam A; Ulas T; Aschenbrenner AC; Kaiser F; Kubaczka C; Schultze JL; Schorle H; Krämer B; Knoll R; Bonaguro L; ToVinh M; Raabe J; Astaburuaga-García R; Schulte-Schrepping J; Kaiser KM; Rieke GJ; Bischoff J; Monin MB; Hoffmeister C; Schlabe S; De Domenico E; Reusch N; Händler K; Reynolds G; Blüthgen N; Hack G; Finnemann C; Nischalke HD; Strassburg CP; Stephenson E; Su Y; Gardner L; Yuan D; Chen D; Goldman J; Rosenstiel P; Schmidt SV; Latz E; Hrusovsky K; Ball AJ; Johnson JM; Koenig PA; Schmidt FI; Haniffa M; Heath JR; Kümmerer BM; Keitel V; Jensen B; Stubbemann P; Kurth F; Sander LE; Sawitzki B; Aschenbrenner AC; Schultze JL; Nattermann J; Kern P; Balzer NR; Blank N; Cygon C; Wunderling K; Bender F; Frolov A; Sowa JP; Bonaguro L; Ulas T; Homrich M; Kiermaier E; Thiele C; Schultze JL; Canbay A; Bauer R; Mass E; Warnat-Herresthal S; Schultze H; Shastry KL; Manamohan S; Mukherjee S; Garg V; Sarveswara R; Händler K; Pickkers P; Aziz NA; Ktena S; Tran F; Bitzer M; Ossowski S; Casadei N; Herr C; Petersheim D; Behrends U; Kern F; Fehlmann T; Schommers P; Lehmann C; Augustin M; Rybniker J; Altmüller J; Mishra N; Bernardes JP; Krämer B; Bonaguro L; Schulte-Schrepping J; De Domenico E; Siever C; Kraut M; Desai M; Monnet B; Saridaki M; Siegel CM; Drews A; Nuesch-Germano M; Theis H; Heyckendorf J; Schreiber S; Kim-Hellmuth S; Nattermann J; Skowasch D; Kurth I; Keller A; Bals R; Nürnberg P; Rieß O; Rosenstiel P; Netea MG; Theis F; Mukherjee S; Backes M; Aschenbrenner AC; Ulas T; Breteler MMB; Giamarellos-Bourboulis EJ; Kox M; Becker M; Cheran S; Woodacre MS; Goh EL; Schultze JL; Reusch N; De Domenico E; Bonaguro L; Schulte-Schrepping J; Baßler K; Schultze JL; Aschenbrenner AC; Beckert V; Rassmann S; Kayvanjoo AH; Klausen C; Bonaguro L; Botermann DS; Krause M; Moreth K; Spielmann N; da Silva-Buttkus P; Fuchs H; Gailus-Durner V; de Angelis MH; Händler K; Ulas T; Aschenbrenner AC; Mass E; Wachten D; Aschenbrenner AC; Mouktaroudi M; Krämer B; Oestreich M; Antonakos N; Nuesch-Germano M; Gkizeli K; Bonaguro L; Reusch N; Baßler K; Saridaki M; Knoll R; Pecht T; Kapellos TS; Doulou S; Kröger C; Herbert M; Holsten L; Horne A; Gemünd ID; Rovina N; Agrawal S; Dahm K; van Uelft M; Drews A; Lenkeit L; Bruse N; Gerretsen J; Gierlich J; Becker M; Händler K; Kraut M; Theis H; Mengiste S; De Domenico E; Schulte-Schrepping J; Seep L; Raabe J; Hoffmeister C; ToVinh M; Keitel V; Rieke G; Talevi V; Skowasch D; Aziz NA; Pickkers P; van de Veerdonk FL; Netea MG; Schultze JL; Kox M; Breteler MMB; Nattermann J; Koutsoukou A; Giamarellos-Bourboulis EJ; Ulas T; De Domenico E; Bonaguro L; Schulte-Schrepping J; Becker M; Händler K; Schultze JL; Bonaguro L; Köhne M; Schmidleithner L; Schulte-Schrepping J; Warnat-Herresthal S; Horne A; Kern P; Günther P; Ter Horst R; Jaeger M; Rahmouni S; Georges M; Falk CS; Li Y; Mass E; Beyer M; Joosten LAB; Netea MG; Ulas T; Schultze JL; Aschenbrenner AC; Schulte-Schrepping J; Reusch N; Paclik D; Baßler K; Schlickeiser S; Zhang B; Krämer B; Krammer T; Brumhard S; Bonaguro L; De Domenico E; Wendisch D; Grasshoff M; Kapellos TS; Beckstette M; Pecht T; Saglam A; Dietrich O; Mei HE; Schulz AR; Conrad C; Kunkel D; Vafadarnejad E; Xu CJ; Horne A; Herbert M; Drews A; Thibeault C; Pfeiffer M; Hippenstiel S; Hocke A; Müller-Redetzky H; Heim KM; Machleidt F; Uhrig A; Bosquillon de Jarcy L; Jürgens L; Stegemann M; Glösenkamp CR; Volk HD; Goffinet C; Landthaler M; Wyler E; Georg P; Schneider M; Dang-Heine C; Neuwinger N; Kappert K; Tauber R; Corman V; Raabe J; Kaiser KM; Vinh MT; Rieke G; Meisel C; Ulas T; Becker M; Geffers R; Witzenrath M; Drosten C; Suttorp N; von Kalle C; Kurth F; Händler K; Schultze JL; Aschenbrenner AC; Li Y; Nattermann J; Sawitzki B; Saliba AE; Sander LE; Kapellos TS; Bonaguro L; Gemünd I; Reusch N; Saglam A; Hinkley ER; Schultze JL",
    ad = {German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany.Electronic address: tobias.grass@dzne.de.; German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany.; German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany.; German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany;Technische Universität Dresden (TUD), Center for Regenerative Therapies Dresden,Dresden, Germany.; German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany.; German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany.; German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany.; Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany.; DRESDEN-concept Genome Center, Technology Platform at the Center for Molecularand Cellular Bioengineering, TUD, Dresden, Germany.; Max Planck Institute for Molecular Cell Biology and Genetics, Dresden, Germany;Center for Systems Biology Dresden, Dresden, Germany.; Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany;Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany;Center for Rare Diseases, University Hospital of Cologne, Cologne, Germany.; Systems Medicine, DZNE, Bonn, Germany; PRECISE Platform for Single Cell Genomicsand Epigenomics, DZNE \& University of Bonn and West German Genome Center, Bonn,Germany; Immunogenomics \& Neurodegeneration, DZNE, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany; Genomics \& Immunoregulation, LIMESInstitute, University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases e.V. (DZNE), Dresden, Germany;Technische Universität Dresden (TUD), Center for Regenerative Therapies Dresden,Dresden, Germany; Max Planck Institute for Molecular Cell Biology and Genetics,Dresden, Germany. Electronic address: natalia.rodriguez-muela@dzne.de.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Translational Pediatrics, Department of Pediatrics, UniversityHospital Würzburg, Würzburg, Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health atCharité - Universitätsmedizin Berlin, Berlin, Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center forInfection Research (HZI), Würzburg, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Genomics \& Immunoregulation, Life \& Medical Sciences Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Genomics \& Immunoregulation, Life \& Medical Sciences Institute,University of Bonn, Bonn, Germany; Department of Microbiology and Immunology, TheUniversity of Melbourne at the Peter Doherty Institute for Infection andImmunity, Melbourne, VIC, Australia.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE,University of Bonn, and West German Genome Center, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE,University of Bonn, and West German Genome Center, Bonn, Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE, University ofBonn, and West German Genome Center, Bonn, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany; BIH Biomedical Innovation Academy,BIH Charité Clinician Scientist Program, Berlin Institute of Health at Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE, University ofBonn, and West German Genome Center, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE, University ofBonn, and West German Genome Center, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE,University of Bonn, and West German Genome Center, Bonn, Germany; Immunogenomics\& Neurodegeneration, Systems Medicine, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), Bonn, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany.; Department of Hepatology and Gastroenterology, Charité - UniversitätsmedizinBerlin, Berlin, Germany.; Department of Respiratory Medicine, Medical Clinic I, Goethe-UniversitätFrankfurt am Main, Frankfurt, Germany; Biomedical Research in Endstage andObstructive Lung Disease Hannover (BREATH), Member of the German Center for LungResearch (DZL), Hannover, Germany; CAPNETZ STIFTUNG, 30625 Hannover, Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany; CAPNETZ STIFTUNG, 30625 Hannover,Germany; German Center for Lung Research (DZL), Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany; CAPNETZ STIFTUNG, 30625 Hannover,Germany; German Center for Lung Research (DZL), Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center forInfection Research (HZI), Würzburg, Germany; Faculty of Medicine, Institute ofMolecular Infection Biology (IMIB), University of Würzburg, Josef-Schneider-Str.2, 97080 Würzburg, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Genomics \& Immunoregulation, Life \& Medical Sciences Institute,University of Bonn, Bonn, Germany; PRECISE Platform for Single Cell Genomics andEpigenomics, DZNE, University of Bonn, and West German Genome Center, Bonn,Germany.; BIH Center for Regenerative Therapies (BCRT), Berlin Institute of Health atCharité - Universitätsmedizin Berlin, Berlin, Germany; German Rheumatism ResearchCentre (DRFZ) Berlin, Berlin, Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany; BIH Center for RegenerativeTherapies (BCRT), Berlin Institute of Health at Charité - UniversitätsmedizinBerlin, Berlin, Germany; German Center for Lung Research (DZL), Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Genomics \& Immunoregulation, Life \& Medical Sciences Institute,University of Bonn, Bonn, Germany; PRECISE Platform for Single Cell Genomics andEpigenomics, DZNE, University of Bonn, and West German Genome Center, Bonn,Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany. Electronic address: anna.aschenbrenner@dzne.de.; Department of Infectious Diseases and Critical Care Medicine, Charité -Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL), Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE) eV.;Genomics \& Immunoregulation, LIMES Institute, University of Bonn.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE) eV.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE) eV.;PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn; Immunogenomics \& Neurodegeneration, German Center for NeurodegenerativeDiseases (DZNE) eV.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE) eV.;Genomics \& Immunoregulation, LIMES Institute, University of Bonn; PRECISEPlatform for Single Cell Genomics and Epigenomics, DZNE and University of Bonn.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE) eV.;Genomics \& Immunoregulation, LIMES Institute, University of Bonn.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE) eV.;Genomics \& Immunoregulation, LIMES Institute, University of Bonn.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE) eV.;Genomics \& Immunoregulation, LIMES Institute, University of Bonn;lorenzobonaguro@uni-bonn.de.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics,The University of Queensland, Brisbane, QLD, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland,Brisbane, QLD, Australia.; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD,Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics,The University of Queensland, Brisbane, QLD, Australia.; School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics,The University of Queensland, Brisbane, QLD, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Respiratory Bioinformatics and Molecular Biology, School of Life Sciences,University of Technology Sydney, Sydney, NSW, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Frazer Institute, University of Queensland, Woolloongabba, QLD, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Frazer Institute, University of Queensland, Woolloongabba, QLD, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; Sydney Cytometry, Charles Perkins Centre, Centenary Institute and The Universityof Sydney, Sydney, NSW, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University ofSydney, Sydney, NSW, Australia.; Sydney Cytometry, Charles Perkins Centre, Centenary Institute and The Universityof Sydney, Sydney, NSW, Australia.; Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre and TheUniversity of Sydney, Sydney, NSW, Australia.; Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre and TheUniversity of Sydney, Sydney, NSW, Australia.; Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre and TheUniversity of Sydney, Sydney, NSW, Australia.; Sydney Cytometry, Charles Perkins Centre, Centenary Institute and The Universityof Sydney, Sydney, NSW, Australia.; Marie Bashir Institute for Infectious Diseases and Biosecurity, The University ofSydney, Sydney, NSW, Australia.; Ramaciotti Facility for Human Systems Biology, Charles Perkins Centre and TheUniversity of Sydney, Sydney, NSW, Australia.; Discipline of Pathology, Faculty of Medicine and Health, School of MedicalSciences, The University of Sydney, Sydney, NSW, Australia.; Sydney Mass Spectrometry, The University of Sydney, Sydney, NSW, Australia.; Sydney Mass Spectrometry, The University of Sydney, Sydney, NSW, Australia.; School of Life and Environmental Sciences, Charles Perkins Centre and TheUniversity of Sydney, Sydney, NSW, Australia.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Frazer Institute, University of Queensland, Woolloongabba, QLD, Australia.; Lydia Becker Institute of Immunology and Inflammation, University of Manchester,Manchester, UK.; Centre for Innate Immunity and Infectious Diseases and Department of Molecularand Translational Science, Hudson Institute of Medical Research and MonashUniversity, Melbourne, VIC, Australia.; Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD,Australia.; Division of Pulmonary and Critical Care Medicine, Laura and Isaac PerlmutterCancer Center, New York University Grossman School of Medicine, NYU LangoneHealth, New York, NY, USA.; Lee Kong Chian School of Medicine, Translational Respiratory Research Laboratory,Singapore.; Mater Research Institute, Faculty of Medicine, University of Queensland,Brisbane, QLD, Australia.; Department of Dietetics \& Food Services, Mater Hospital, Brisbane, QLD,Australia.; UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland,Brisbane, QLD, Australia.; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD,Australia.; UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland,Brisbane, QLD, Australia.; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD,Australia.; UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland,Brisbane, QLD, Australia.; Department of Thoracic Medicine, The Prince Charles Hospital, Chermside, QLD,Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia.; School of Earth and Environmental Sciences, The University of Queensland,Brisbane, QLD, Australia.; School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics,The University of Queensland, Brisbane, QLD, Australia.; Priority Research Centre for Healthy Lungs and Immune Health Research Program,The University of Newcastle and Hunter Medical Research Institute, Newcastle,NSW, Australia Philip.Hansbro@uts.edu.au.; Centre for Inflammation, Centenary Institute, Sydney, NSW, Australia.; School of Life Sciences, Faculty of Science, University of Technology Sydney,Sydney, NSW, Australia.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute, University ofBonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute, University ofBonn, Bonn, Germany.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute, University ofBonn, Bonn, Germany.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Systems Hematology, Stem Cells \& Precision Medicine, Max Delbrück Center - BerlinInstitute for Medical Systems Biology (MDCBIMSB), Berlin, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; In Vivo Cell Biology of Infection, Max Planck Institute for Infection Biology(MPIIB), Berlin, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Broad Institute at Massachusetts Institute of Technology (MIT) and Harvard,Boston, MA, United States.; Ragon Institute of Mass General Hospital (MGH), MIT, and Harvard, Cambridge, MA,United States.; Department of Chemistry, Institute for Medical Engineering and Science, KochInstitute, Cambridge, MA, United States.; Platform for Single Cell Genomics and Epigenomics (PRECISE), DZNE and Universityof Bonn, Bonn, Germany.; Institute for Human Genetics, University Hospital Schleswig-Holstein, Lübeck,Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics (PRECISE), DZNE and Universityof Bonn, Bonn, Germany.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Immunology and Metabolism, Life and Medical Sciences Institute, University ofBonn, Bonn, Germany.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Department of Medical Genetics, Iuliu Hatieganu University of Medicine andPharmacy, Cluj-Napoca, Romania.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen,Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute, University ofBonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics (PRECISE), DZNE and Universityof Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany. Electronic address:caterina.carraro@dzne.de.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany; PRECISE Platform forGenomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen(DZNE) e.V. and University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany; PRECISE Platform forGenomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen(DZNE) e.V. and University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Immunogenomics \& Neurodegeneration, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V., Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Immunogenomics \& Neurodegeneration, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V., Bonn, Germany.; PRECISE Platform for Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn, Bonn, Germany.; PRECISE Platform for Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn, Bonn, Germany.; Department of Surgery, University of Cambridge, and Cambridge NIHR BiomedicalResearch Centre, Cambridge, UK.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Core Research Facilities and Services, Light Microscope Facility (LMF), DeutschesZentrum für Neurodegenerative Erkrankungen (DZNE) e.V., Bonn, Germany.; Core Research Facilities and Services, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE) e.V., Bonn, Germany.; Core Research Facilities and Services, Light Microscope Facility (LMF), DeutschesZentrum für Neurodegenerative Erkrankungen (DZNE) e.V., Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany; PRECISE Platform forGenomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen(DZNE) e.V. and University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; PRECISE Platform for Genomics and Epigenomics, DeutschesZentrum für Neurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn,Bonn, Germany; Immunogenomics \& Neurodegeneration, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V., Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; PRECISE Platform for Genomics and Epigenomics, DeutschesZentrum für Neurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn,Bonn, Germany. Electronic address: a.saglam1980@gmail.com.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany; PRECISE Platform forGenomics and Epigenomics, Deutsches Zentrum für Neurodegenerative Erkrankungen(DZNE) e.V. and University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; LIMES-Institute, Laboratory for Genomics and Immunoregulation, University ofBonn, Bonn, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), Bonn, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), Bonn, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), Bonn, Germany.; Department of Microbiology and Immunology, The Peter Doherty Institute forInfection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), Bonn, Germany.; Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig,Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), Bonn, Germany.; Laboratory of Experimental Immunology, WPI Immunology Frontier Research Center,Osaka University, Osaka, Japan.; Molecular Immunology, Robinson Research Institute, University of Adelaide,Norwich Centre, North Adelaide, SA, Australia.; LIMES-Institute, Laboratory for Genomics and Immunoregulation, University ofBonn, Bonn, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), Bonn, Germany.; Laboratory of Experimental Immunology, WPI Immunology Frontier Research Center,Osaka University, Osaka, Japan.; Molecular Immunology, Robinson Research Institute, University of Adelaide,Norwich Centre, North Adelaide, SA, Australia.; Experimental Immunology, Helmholtz Centre for Infection Research, Braunschweig,Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; LIMES-Institute, Laboratory for Genomics and Immunoregulation, University ofBonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; LIMES-Institute, Laboratory for Genomics and Immunoregulation, University ofBonn, Bonn, Germany.; PRECISE, Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), Bonn, Germany.; PRECISE, Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany; Comprehensive Pneumology Center (CPC),Institute of Lung Health and Immunity (LHI), Member of the German Center for LungResearch (DZL), Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Centre for Inflammation, Centenary Institute and University of Technology Sydney,School of Life Sciences, Faculty of Science, Sydney, NSW 2007, Australia.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, 85764Neuherberg, Germany; Department of Mathematics, Technische Universität München,85748 Garching, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany; Platform for Single Cell Genomics andEpigenomics (PRECISE), German Center for Neurodegenerative Diseases and theUniversity of Bonn, 53127 Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Centre for Inflammation, Centenary Institute and University of Technology Sydney,School of Life Sciences, Faculty of Science, Sydney, NSW 2007, Australia.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center forNeurodegenerative Diseases and the University of Bonn, 53127 Bonn, Germany.; Computational Life Sciences, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany; Institute of Computational Biology(ICB), Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center forNeurodegenerative Diseases and the University of Bonn, 53127 Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; University of Technology Sydney, School of Life Sciences, Faculty of Science,Sydney, NSW 2007, Australia; Immune Health, Hunter Medical Research Institute,New Lambton and The University of Newcastle, Newcastle, NSW 2305, Australia.; University of Technology Sydney, School of Life Sciences, Faculty of Science,Sydney, NSW 2007, Australia; Immune Health, Hunter Medical Research Institute,New Lambton and The University of Newcastle, Newcastle, NSW 2305, Australia.; School of Biomedical Engineering, Faculty of Engineering and IT, University ofTechnology Sydney, Garvan Institute of Medical Research, and St Vincent'sClinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW2010, Australia.; Department of Pathology and Medical Biology, University of Groningen, UniversityMedical Center Groningen, 9700 AB Groningen, the Netherlands; GRIAC ResearchInstitute, University Medical Center Groningen, 9700 RB Groningen, theNetherlands.; Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity(LHI), Member of the German Center for Lung Research (DZL), Helmholtz ZentrumMünchen, 85764 Neuherberg, Germany; Institute of Computational Biology (ICB),Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Immunregulation, German Center for Neurodegenerative Diseases (DZNE), 53127 Bonn,Germany.; Immunregulation, German Center for Neurodegenerative Diseases (DZNE), 53127 Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Respiratory Translational Research Group, Department of Laboratory Medicine,School of Health Sciences, College of Health and Medicine, University ofTasmania, Launceston, 7250 TAS, Australia.; Respiratory Translational Research Group, Department of Laboratory Medicine,School of Health Sciences, College of Health and Medicine, University ofTasmania, Launceston, 7250 TAS, Australia.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, 53115 Bonn, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), 53127 Bonn, Germany.; Department of Pathology and Medical Biology, University of Groningen, UniversityMedical Center Groningen, 9700 AB Groningen, the Netherlands; Department ofPulmonary Diseases, University of Groningen, University Medical Center Groningen,9713 GZ Groningen, the Netherlands.; Department of Pathology and Medical Biology, University of Groningen, UniversityMedical Center Groningen, 9700 AB Groningen, the Netherlands; Department ofPulmonary Diseases, University of Groningen, University Medical Center Groningen,9713 GZ Groningen, the Netherlands.; Department of Pathology and Medical Biology, University of Groningen, UniversityMedical Center Groningen, 9700 AB Groningen, the Netherlands; Department ofPulmonary Diseases, University of Groningen, University Medical Center Groningen,9713 GZ Groningen, the Netherlands.; Respiratory Translational Research Group, Department of Laboratory Medicine,School of Health Sciences, College of Health and Medicine, University ofTasmania, Launceston, 7250 TAS, Australia.; Department of Internal Medicine II, Pneumology, University Hospital Bonn, 53127Bonn, Germany.; Department of Internal Medicine II, Pneumology, University Hospital Bonn, 53127Bonn, Germany.; University Clinics for Radiology, University Hospital Bonn, 53127 Bonn, Germany.; Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity(LHI), Member of the German Center for Lung Research (DZL), Helmholtz ZentrumMünchen, 85764 Neuherberg, Germany.; Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity(LHI), Member of the German Center for Lung Research (DZL), Helmholtz ZentrumMünchen, 85764 Neuherberg, Germany.; Department of Pathology and Medical Biology, University of Groningen, UniversityMedical Center Groningen, 9700 AB Groningen, the Netherlands; GRIAC ResearchInstitute, University Medical Center Groningen, 9700 RB Groningen, theNetherlands.; Modular HPC and AI, German Center for Neurodegenerative Diseases (DZNE), 53127Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center forNeurodegenerative Diseases and the University of Bonn, 53127 Bonn, Germany;Institute of Human Genetics, University of Lübeck, 23562 Lübeck, Germany.; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center forNeurodegenerative Diseases and the University of Bonn, 53127 Bonn, Germany;Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseases(DZNE), 53127 Bonn, Germany.; Immunregulation, German Center for Neurodegenerative Diseases (DZNE), 53127 Bonn,Germany.; Platform for Single Cell Genomics and Epigenomics (PRECISE), German Center forNeurodegenerative Diseases and the University of Bonn, 53127 Bonn, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, 85764Neuherberg, Germany; Department of Mathematics, Technische Universität München,85748 Garching, Germany; Computational Life Sciences, Life \& Medical Sciences(LIMES) Institute, University of Bonn, 53115 Bonn, Germany.; Department of Internal Medicine II, Pneumology, University Hospital Bonn, 53127Bonn, Germany.; Institute of Computational Biology (ICB), Helmholtz Zentrum München, 85764Neuherberg, Germany; Department of Mathematics, Technische Universität München,85748 Garching, Germany.; Centre for Inflammation, Centenary Institute and University of Technology Sydney,School of Life Sciences, Faculty of Science, Sydney, NSW 2007, Australia;University of Technology Sydney, School of Life Sciences, Faculty of Science,Sydney, NSW 2007, Australia.; Respiratory Translational Research Group, Department of Laboratory Medicine,School of Health Sciences, College of Health and Medicine, University ofTasmania, Launceston, 7250 TAS, Australia.; Comprehensive Pneumology Center (CPC), Institute of Lung Health and Immunity(LHI), Member of the German Center for Lung Research (DZL), Helmholtz ZentrumMünchen, 85764 Neuherberg, Germany; Department of Mathematics, TechnischeUniversität München, 85748 Garching, Germany. Electronic address:j.schultze@uni-bonn.de.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany; Genomics and Immunoregulation, Life \& Medical Sciences(LIMES) Institute, University of Bonn, 53113 Bonn, Germany. Electronic address:lorenzobonaguro@uni-bonn.de.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Immunogenomics and Neurodegeneration, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Department of Microbiology and Immunology, Peter Doherty Institute for Infectionand Immunity, The University of Melbourne, Parkville, VIC, Australia.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Immunogenomics and Neurodegeneration, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Department of Pharmaceutical and Pharmacological Sciences, University of Padova,35131 Padova, Italy.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Comma Soft AG, 53229 Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Department of Microbiology and Immunology, the University of Melbourne, at thePeter Doherty Institute for Infection and Immunity, Parkville, 3010 VIC,Australia.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Unit of Animal Genomics, GIGA-Institute, University of Liège, 4000 Liège,Belgium.; Unit of Animal Genomics, GIGA-Institute, University of Liège, 4000 Liège,Belgium.; Department of Human Genetics and Radboud Institute for Molecular Life Sciences,Radboud University Medical Center, 6525 Nijmegen, the Netherlands.; Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SAPathology and the University of South Australia, Adelaide, 5000 SA, Australia.; Department of Human Genetics and Radboud Institute for Molecular Life Sciences,Radboud University Medical Center, 6525 Nijmegen, the Netherlands.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, 6525 Nijmegen, the Netherlands.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, 6525 Nijmegen, the Netherlands.; Department of Medical Genetics, "Iuliu Hatieganu" University of Medicine andPharmacy, 400012 Cluj-Napoca, Romania.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, 6525 Nijmegen, the Netherlands.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, 6525 Nijmegen, the Netherlands.; Immunology and Metabolism, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE and University of Bonn, 53127 Bonn, Germany.; Statistics and Machine Learning, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), 53127 Bonn, Germany.; MRC Biostatistics Unit, University of Cambridge, Cambridge CB2 0SR, UK.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE and University of Bonn, 53127 Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE and University of Bonn, 53127 Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),53127 Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, 53113 Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, 6525 Nijmegen, the Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn, Bonn, Germany.; Genomics \& Immunoregulation, LIMES Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn, Bonn, Germany.; Genomics \& Immunoregulation, LIMES Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn, Bonn, Germany.; Genomics \& Immunoregulation, LIMES Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn, Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, the Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn, Bonn, Germany.; Immunogenomics \& Neurodegeneration, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE) e.V., Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany. Joachim.Schultze@dzne.de.; PRECISE Platform for Single Cell Genomics and Epigenomics, DZNE and University ofBonn, Bonn, Germany. Joachim.Schultze@dzne.de.; Genomics \& Immunoregulation, LIMES Institute, University of Bonn, Bonn, Germany.Joachim.Schultze@dzne.de.; Department of Pharmaceutical and Pharmacological Sciences, University of Padova,Padova, Italy.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Institute of Organic Chemistry, Justus Liebig University Giessen, Giessen,Germany.; Department of Pharmaceutical and Pharmacological Sciences, University of Padova,Padova, Italy.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; PRECISE Platform for Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn, Bonn, Germany.; Institute of Human Genetics, University of Lübeck, Lübeck, Germany.; Statistics and Machine Learning, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE) e.V., Bonn, Germany.; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn, Bonn, Germany.; Department of Pharmaceutical and Pharmacological Sciences, University of Padova,Padova, Italy.; Institute of Organic Chemistry, Justus Liebig University Giessen, Giessen,Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn, Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE)e.V., Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) e.V. and University of Bonn, Bonn, Germany.; Department of Pharmaceutical and Pharmacological Sciences, University of Padova,Padova, Italy.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Computational Life Sciences, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Neuherberg, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Comma Soft AG, Bonn, Germany.; Helmholtz Zentrum München - German Research Center for Environmental Health,Institute of Computational Biology, Neuherberg, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseasesand the University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Department of electrical engineering and computer science, University ofCalifornia, Berkeley, CA, United States.; Center for computational biology, University of California, Berkeley, CA, UnitedStates.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Department of Internal Medicine II, University Hospital Bonn, Section ofPneumology, Bonn, Germany.; Department of Internal Medicine II, University Hospital Bonn, Section ofPneumology, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Prevention, Aging \& Systems Immunology, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Prevention, Aging \& Systems Immunology, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Computational Biology, Boehringer Ingelheim Pharma GmbH \& Co. KG, Biberach,Germany.; Comma Soft AG, Bonn, Germany.; Comma Soft AG, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Institute for Medical Engineering \& Science, Department of Chemistry, and KochInstitute for Integrative Cancer Research, Massachusetts Institute of Technology,Cambridge, MA, United States.; Broad Institute of MIT and Harvard; Ragon Institute of MGH, MIT and Harvard,Cambridge, MA, United States.; Institute of Structural Biology, University Hospital, University of Bonn, Bonn,Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Institute of Structural Biology, University Hospital, University of Bonn, Bonn,Germany.; Biochemistry \& Cell Biology of Lipids, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; University Clinics for Radiology, University Hospital Bonn, Bonn, Germany.; Institute for Medical Engineering \& Science, Department of Chemistry, and KochInstitute for Integrative Cancer Research, Massachusetts Institute of Technology,Cambridge, MA, United States.; Broad Institute of MIT and Harvard; Ragon Institute of MGH, MIT and Harvard,Cambridge, MA, United States.; University Clinics for Radiology, University Hospital Bonn, Bonn, Germany.; University Clinics for Radiology, University Hospital Bonn, Bonn, Germany.; Comma Soft AG, Bonn, Germany.; Immunogenomics \& Neurodegeneration, German Center for Neurodegenerative Diseasesand the University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Translational Medicine \& Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH\& Co. KG, Biberach, Germany.; Department of electrical engineering and computer science, University ofCalifornia, Berkeley, CA, United States.; Center for computational biology, University of California, Berkeley, CA, UnitedStates.; Chan-Zuckerberg Biohub, San Francisco, CA, United States.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States.; Prevention, Aging \& Systems Immunology, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), Bonn, Germany.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, United States.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, Netherlands.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Computational Life Sciences, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Neuherberg, Germany.; Helmholtz Zentrum München - German Research Center for Environmental Health,Institute of Computational Biology, Neuherberg, Germany.; Helmholtz Zentrum München - German Research Center for Environmental Health,Institute of Computational Biology, Neuherberg, Germany.; School of Life Sciences Weihenstephan, Technical University of Munich, Munich,Germany, Department of Mathematics, Technical University of Munich, Munich,Germany.; Department of Internal Medicine II, University Hospital Bonn, Section ofPneumology, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany;IRI Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany; Systems Medicine, Deutsches Zentrum fürNeurodegenerativen Erkrankungen (DZNE), Bonn, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London,UK; Department of Biochemistry, Charité - Universitätsmedizin Berlin, Berlin,Germany; Department of Biochemistry, Cambridge Centre for Proteomics, Universityof Cambridge, Cambridge, UK.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany; PRECISE Platform for Genomics and Epigenomicsat DZNE, University of Bonn, Bonn, Germany; Department of Microbiology andImmunology, The University of Melbourne at the Peter Doherty Institute forInfection and Immunity, Melbourne, Victoria, Australia.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Core Facility, High Throughput Mass Spectrometry, Charité - UniversitätsmedizinBerlin, Berlin, Germany.; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London,UK.; Institute of Pathology, University Clinic Aachen, RWTH Aachen, Aachen, Germany.; Institute of Pathology, University Clinic Aachen, RWTH Aachen, Aachen, Germany.; Mass Cytometry Laboratory, DRFZ Berlin, A Leibniz Institute, Berlin, Germany.; Mass Cytometry Laboratory, DRFZ Berlin, A Leibniz Institute, Berlin, Germany.; Si-M/"Der Simulierte Mensch" a Science Framework of Technische Universität Berlinand Charité - Universitätsmedizin Berlin, Berlin, Germany; Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt - Universität zu Berlin, and Berlin Institute of Health, Berlin,Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz Center forInfection Research (HZI), Würzburg, Germany.; Center for Digital Health, Berlin Institute of Health (BIH), Charité -Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL), Berlin, Germany.; Center for Digital Health, Berlin Institute of Health (BIH), Charité -Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL), Berlin, Germany.; Department of Pediatric Respiratory Medicine, Immunology and Critical CareMedicine, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Centerfor Lung Research (DZL), Associated Partner, Berlin, Germany; Berlin Institute ofHealth (BIH), Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Pediatric Respiratory Medicine, Immunology and Critical CareMedicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Pediatric Respiratory Medicine, Immunology and Critical CareMedicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Core Unit Bioinformatics, Berlin Institute of Health (BIH), Charité -Universitätsmedizin Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, BerlinInstitute for Medical Systems Biology, Berlin, Germany.; IRI Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany;Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, BerlinInstitute for Medical Systems Biology, Berlin, Germany.; Core Unit Bioinformatics, Berlin Institute of Health (BIH), Charité -Universitätsmedizin Berlin, Berlin, Germany.; Institute of Pathology, University Clinic Aachen, RWTH Aachen, Aachen, Germany.; Institute of Pathology, University Clinic Aachen, RWTH Aachen, Aachen, Germany;Department of Nephrology, University Clinic Aachen, RWTH Aachen, Aachen, Germany;Electron Microscopy Facility, University Clinic Aachen, RWTH Aachen, Aachen,Germany.; Department of Hepatology and Gastroenterology, Charité - UniversitätsmedizinBerlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany; German Center for Lung Research(DZL), Gießen, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Institute of Physiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany; Department of Immunology, Labor Berlin, Charité Vivantes, Berlin,Germany.; Molecular Biology of Metabolism Laboratory, The Francis Crick Institute, London,UK; Department of Biochemistry, Charité - Universitätsmedizin Berlin, Berlin,Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany; Systems Medicine, Deutsches Zentrum fürNeurodegenerativen Erkrankungen (DZNE), Bonn, Germany; PRECISE Platform forGenomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany; Systems Medicine, Deutsches Zentrum fürNeurodegenerativen Erkrankungen (DZNE), Bonn, Germany; PRECISE Platform forGenomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany; Departmentof Internal Medicine, Radboud Center for Infectious Diseases, Radboud UniversityMedical Center, Nijmegen, the Netherlands.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany; Department of Tropical Medicine,Bernhard Nocht Institute for Tropical Medicine, Department of Medicine I,University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité -Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin,Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany;IRI Life Sciences, Humboldt-Universität zu Berlin, Berlin, Germany.; Institute of Medical Immunology, Charité - Universitätsmedizin Berlin, Berlin,Germany; Berlin Institute of Health (BIH), Charité - Universitätsmedizin Berlin,Berlin, Germany. Electronic address: birgit.sawitzki@charite.de.; Institute of Pathology, Department of Developmental Pathology, UniversityHospital Bonn, University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; Institute of Pathology, Department of Developmental Pathology, UniversityHospital Bonn, University of Bonn, Bonn, Germany.; Institute of Pathology, Department of Developmental Pathology, UniversityHospital Bonn, University of Bonn, Bonn, Germany.; Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn,University of Bonn, Bonn, Germany.; Institute of Pathology, Department of Developmental Pathology, UniversityHospital Bonn, University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE), Bonn, Germany and University of Bonn,Bonn, Germany.; Molecular Immunology in Neurodegeneration, DZNE, Bonn, Germany.; Department of Microbiology and Immunology, The Peter Doherty Institute forInfection and Immunity, University of Melbourne, Melbourne, VIC, Australia.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE), Bonn, Germany and University of Bonn,Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE), Bonn, Germany and University of Bonn,Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE), Bonn, Germany and University of Bonn,Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, The Netherlands.; Institute of Pathology, Department of Developmental Pathology, UniversityHospital Bonn, University of Bonn, Bonn, Germany.; Institute of Pathology, Department of Developmental Pathology, UniversityHospital Bonn, University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, DZNE, Bonn, Germany and University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE), Bonn, Germany and University of Bonn,Bonn, Germany.; Institute of Pathology, Department of Developmental Pathology, UniversityHospital Bonn, University of Bonn, Bonn, Germany. schorle@uni-bonn.de.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Life and Medical Sciences (LIMES) Institute, University of Bonn,Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Life and Medical Sciences (LIMES) Institute, University of Bonn,Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Charité - Universitätsmedizin Berlin, corporate member of Freie UniversitätBerlin, Humboldt- Universität zu Berlin, Institute of Pathology, Berlin, Germany;IRI Life Sciences \& Institute of Theoretical Biology, Humboldt-Universität zuBerlin, Berlin, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Life and Medical Sciences (LIMES) Institute, University of Bonn,Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany;German Center for Infection Research (DZIF), Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),PRECISE Platform for Genomics and Epigenomics at DZNE, and University of Bonn,Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Life and Medical Sciences (LIMES) Institute, University of Bonn,Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),PRECISE Platform for Genomics and Epigenomics at DZNE, and University of Bonn,Bonn, Germany.; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.; Charité - Universitätsmedizin Berlin, corporate member of Freie UniversitätBerlin, Humboldt- Universität zu Berlin, Institute of Pathology, Berlin, Germany;IRI Life Sciences \& Institute of Theoretical Biology, Humboldt-Universität zuBerlin, Berlin, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.; Institute for Systems Biology, Seattle, WA 98109, USA.; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.; Institute for Systems Biology, Seattle, WA 98109, USA.; Institute for Systems Biology, Seattle, WA 98109, USA.; Institute for Systems Biology, Seattle, WA 98109, USA; Swedish Center forResearch and Innovation, Swedish Medical Center, Seattle, WA 98109, USA;Providence St. Joseph Health, Renton, WA 98057, USA; Division of Allergy \&Infectious Diseases, University of Washington, Seattle, WA 98109, USA.; Institute of Clinical Molecular Biology, Kiel University and University MedicalCenter Schleswig-Holstein, Kiel, Germany.; Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.; Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany.; Quanterix Corporation, Billerica, MA, USA.; Quanterix Corporation, Billerica, MA, USA.; Quanterix Corporation, Billerica, MA, USA.; Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany;Core Facility Nanobodies, Medical Faculty, University of Bonn, Bonn, Germany.; Institute of Innate Immunity, Medical Faculty, University of Bonn, Bonn, Germany;Core Facility Nanobodies, Medical Faculty, University of Bonn, Bonn, Germany.; Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK; WellcomeSanger Institute, Wellcome Genome Campus, Cambridge, UK; NIHR NewcastleBiomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastleupon Tyne, UK; Department of Dermatology, Newcastle Hospitals NHS FoundationTrust, Newcastle upon Tyne, UK.; Institute for Systems Biology, Seattle, WA 98109, USA; Board of Directors ofIsoplexis, Branford, CT 06405, USA; Department of Bioengineering, University ofWashington, Seattle, WA 98105, USA; Board of Directors of PACT Pharma, South SanFrancisco, CA 94080, USA.; German Center for Infection Research (DZIF), Germany; Institute of Virology,Medical Faculty, University of Bonn, Bonn, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, UniversityHospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, UniversityHospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Department of Infectious Diseases and Respiratory Medicine, CharitéUniversitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, CharitéUniversitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL), Germany.; Department of Infectious Diseases and Respiratory Medicine, CharitéUniversitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL), Germany.; Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin,Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Life and Medical Sciences (LIMES) Institute, University of Bonn,Bonn, Germany; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),PRECISE Platform for Genomics and Epigenomics at DZNE, and University of Bonn,Bonn, Germany; Department of Internal Medicine and Radboud Center for InfectiousDiseases (RCI), Radboud University Medical Center, Nijmegen, the Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany; Life and Medical Sciences (LIMES) Institute, University of Bonn,Bonn, Germany; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),PRECISE Platform for Genomics and Epigenomics at DZNE, and University of Bonn,Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany;German Center for Infection Research (DZIF), Germany. Electronic address:jacob.nattermann@ukbonn.de.; Developmental Biology of the Immune System, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Developmental Genetics \& Molecular Physiology, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Developmental Biology of the Immune System, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Developmental Biology of the Immune System, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Developmental Biology of the Immune System, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Biochemistry \& Cell Biology of Lipids, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Developmental Genetics \& Molecular Physiology, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Developmental Biology of the Immune System, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, UniversityHospital Magdeburg, Magdeburg, Germany.; Department of Medicine, Ruhr University Bochum, University HospitalKnappschaftskrankenhaus Bochum, Bochum, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics at the Deutsche Zentrum fürNeurodegenerative Erkrankungen (DZNE), University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics at the Deutsche Zentrum fürNeurodegenerative Erkrankungen (DZNE), University of Bonn, Bonn, Germany.; Immune and Tumor Biology, Life \& Medical Sciences (LIMES) Institute, Universityof Bonn, Bonn, Germany.; Immune and Tumor Biology, Life \& Medical Sciences (LIMES) Institute, Universityof Bonn, Bonn, Germany.; Biochemistry \& Cell Biology of Lipids, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics at the Deutsche Zentrum fürNeurodegenerative Erkrankungen (DZNE), University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, UniversityHospital Magdeburg, Magdeburg, Germany.; Department of Medicine, Ruhr University Bochum, University HospitalKnappschaftskrankenhaus Bochum, Bochum, Germany.; Developmental Genetics \& Molecular Physiology, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Developmental Biology of the Immune System, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Hewlett Packard Enterprise, Houston, TX, USA.; Hewlett Packard Enterprise, Houston, TX, USA.; Hewlett Packard Enterprise, Houston, TX, USA.; Hewlett Packard Enterprise, Houston, TX, USA.; Hewlett Packard Enterprise, Houston, TX, USA.; Mesh Dynamics, Bangalore, India.; Hewlett Packard Enterprise, Houston, TX, USA.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Department of Intensive Care Medicine and Radboud Center for Infectious Diseases(RCI), Radboud University Medical Center, Nijmegen, The Netherlands.; Population Health Sciences, Deutsches Zentrum für Neurodegenerative Erkrankungen(DZNE), Bonn, Germany.; Department of Neurology, Faculty of Medicine, University of Bonn, Bonn, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Department of Internal Medicine I, Christian-Albrechts-University and UniversityHospital Schleswig-Holstein, Kiel, Germany.; Institute of Clinical Molecular Biology, Christian-Albrechts-University andUniversity Hospital Schleswig-Holstein, Kiel, Germany.; Department of Internal Medicine I, University Hospital, University of Tübingen,Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, University of Tübingen,Tübingen, Germany.; NGS Competence Center Tübingen, Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, University of Tübingen,Tübingen, Germany.; NGS Competence Center Tübingen, Tübingen, Germany.; Department of Internal Medicine V, Saarland University Hospital, Homburg,Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, University HospitalLMU Munich, Munich, Germany.; Children's Hospital, Medical Faculty, Technical University Munich, Munich,Germany.; Clinical Bioinformatics, Saarland University, Saarbrücken, Germany.; Clinical Bioinformatics, Saarland University, Saarbrücken, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital ofCologne, University of Cologne, Cologne, Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital ofCologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne,Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne,Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital ofCologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne,Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne,Germany.; Department I of Internal Medicine, Faculty of Medicine and University Hospital ofCologne, University of Cologne, Cologne, Germany.; Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne,Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne,Germany.; Cologne Center for Genomics, West German Genome Center, University of Cologne,Cologne, Germany.; Institute of Clinical Molecular Biology, Christian-Albrechts-University andUniversity Hospital Schleswig-Holstein, Kiel, Germany.; Institute of Clinical Molecular Biology, Christian-Albrechts-University andUniversity Hospital Schleswig-Holstein, Kiel, Germany.; Clinical Infectious Diseases, Research Center Borstel and German Center forInfection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel,Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Hewlett Packard Enterprise, Houston, TX, USA.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Hewlett Packard Enterprise, Houston, TX, USA.; Hewlett Packard Enterprise, Houston, TX, USA.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Hewlett Packard Enterprise, Houston, TX, USA.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Clinical Infectious Diseases, Research Center Borstel and German Center forInfection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Borstel,Germany.; Department of Internal Medicine I, Christian-Albrechts-University and UniversityHospital Schleswig-Holstein, Kiel, Germany.; Department of Pediatrics, Dr. von Hauner Children's Hospital, University HospitalLMU Munich, Munich, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Braunschweig, Germany.; Department of Internal Medicine II - Cardiology/Pneumology, University of Bonn,Bonn, Germany.; Institute of Human Genetics, Medical Faculty, RWTH Aachen University, Aachen,Germany.; Clinical Bioinformatics, Saarland University, Saarbrücken, Germany.; Department of Neurology and Neurological Sciences, Stanford University School ofMedicine, Stanford, CA, USA.; Department of Internal Medicine V, Saarland University Hospital, Homburg,Germany.; Cologne Center for Genomics, West German Genome Center, University of Cologne,Cologne, Germany.; Institute of Medical Genetics and Applied Genomics, University of Tübingen,Tübingen, Germany.; NGS Competence Center Tübingen, Tübingen, Germany.; Institute of Clinical Molecular Biology, Christian-Albrechts-University andUniversity Hospital Schleswig-Holstein, Kiel, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, The Netherlands.; Immunology \& Metabolism, Life and Medical Sciences (LIMES) Institute, Universityof Bonn, Bonn, Germany.; Institute of Computational Biology, Helmholtz Center Munich (HMGU), Neuherberg,Germany.; Statistics and Machine Learning, Deutsches Zentrum für NeurodegenerativeErkrankungen (DZNE), Bonn, Germany.; CISPA Helmholtz Center for Information Security, Saarbrücken, Germany.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, The Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Population Health Sciences, Deutsches Zentrum für Neurodegenerative Erkrankungen(DZNE), Bonn, Germany.; Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty ofMedicine, University of Bonn, Bonn, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Department of Intensive Care Medicine and Radboud Center for Infectious Diseases(RCI), Radboud University Medical Center, Nijmegen, The Netherlands.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.; Hewlett Packard Enterprise, Houston, TX, USA.; Hewlett Packard Enterprise, Houston, TX, USA.; Hewlett Packard Enterprise, Houston, TX, USA.; Systems Medicine, Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE),Bonn, Germany. joachim.schultze@dzne.de.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany. joachim.schultze@dzne.de.; PRECISE Platform for Single Cell Genomics and Epigenomics, Deutsches Zentrum fürNeurodegenerative Erkrankungen (DZNE) and the University of Bonn, Bonn, Germany.joachim.schultze@dzne.de.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics \& Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics \& Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics \& Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics \& Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics \& Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics \& Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, University of Bonn, Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases,Radboud University Medical Center, Nijmegen, Netherlands.; Institute of Innate Immunity, Biophysical Imaging, Medical Faculty, University ofBonn, 53127 Bonn, Germany.; Institute of Innate Immunity, Biophysical Imaging, Medical Faculty, University ofBonn, 53127 Bonn, Germany.; Life \& Medical Institute (LIMES), Developmental Biology of the Immune System,University of Bonn, 53115 Bonn, Germany.; Institute of Innate Immunity, Biophysical Imaging, Medical Faculty, University ofBonn, 53127 Bonn, Germany.; Life \& Medical Institute (LIMES), Genomics and Immunoregulation, University ofBonn, 53115 Bonn, Germany.; Institute of Innate Immunity, Biophysical Imaging, Medical Faculty, University ofBonn, 53127 Bonn, Germany.; Institute of Innate Immunity, Biophysical Imaging, Medical Faculty, University ofBonn, 53127 Bonn, Germany.; German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Center Munich,German Research Center for Environmental Health, 85764 Neuherberg, Germany.; German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Center Munich,German Research Center for Environmental Health, 85764 Neuherberg, Germany.; German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Center Munich,German Research Center for Environmental Health, 85764 Neuherberg, Germany.; German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Center Munich,German Research Center for Environmental Health, 85764 Neuherberg, Germany.; German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Center Munich,German Research Center for Environmental Health, 85764 Neuherberg, Germany.; German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Center Munich,German Research Center for Environmental Health, 85764 Neuherberg, Germany; Chairof Experimental Genetics, School of Life Science Weihenstephan, TechnicalUniversity Munich, 85354 Freising, Germany; German Center for Diabetes Research(DZD), 85764 Neuherberg, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform for SingleCell Genomics and Epigenomics at the DZNE and the University of Bonn, 53127 Bonn,Germany.; Life \& Medical Institute (LIMES), Genomics and Immunoregulation, University ofBonn, 53115 Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE),PRECISE Platform for Single Cell Genomics and Epigenomics at the DZNE and theUniversity of Bonn, 53127 Bonn, Germany.; Life \& Medical Institute (LIMES), Genomics and Immunoregulation, University ofBonn, 53115 Bonn, Germany; Department of Internal Medicine and Radboud Center forInfectious Diseases (RCI), Radboud University Medical Center, 6500HB Nijmegen,the Netherlands.; Life \& Medical Institute (LIMES), Developmental Biology of the Immune System,University of Bonn, 53115 Bonn, Germany. Electronic address: emass@uni-bonn.de.; Institute of Innate Immunity, Biophysical Imaging, Medical Faculty, University ofBonn, 53127 Bonn, Germany. Electronic address: dwachten@uni-bonn.de.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, The Netherlands.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Department I of Internal Medicine, University Hospital of Bonn (UKB), Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; 1st Department of Pulmonary Medicine and Intensive Care Unit, National andKapodistrian University of Athens, Medical School, Athens, Greece.; West German Genome Center (WGGC), University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Department of Intensive Care Medicine and Radboud Center for Infectious Diseases(RCI), Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Intensive Care Medicine and Radboud Center for Infectious Diseases(RCI), Radboud University Medical Center, Nijmegen, The Netherlands.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Department I of Internal Medicine, University Hospital of Bonn (UKB), Bonn,Germany.; Department I of Internal Medicine, University Hospital of Bonn (UKB), Bonn,Germany.; Department I of Internal Medicine, University Hospital of Bonn (UKB), Bonn,Germany.; Department of Gastroenterology, Hepatology and Infectious Diseases, UniversityHospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.; Department I of Internal Medicine, University Hospital of Bonn (UKB), Bonn,Germany.; Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE),Bonn, Germany.; Department of Internal Medicine II, Section of Pneumology, University Hospital ofBonn (UKB), Bonn, Germany.; Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE),Bonn, Germany.; Department of Neurology, Faculty of Medicine, University of Bonn, Bonn, Germany.; Department of Intensive Care Medicine and Radboud Center for Infectious Diseases(RCI), Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, The Netherlands.; Immunology \& Metabolism, Life and Medical Sciences (LIMES) Institute, Universityof Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Department of Intensive Care Medicine and Radboud Center for Infectious Diseases(RCI), Radboud University Medical Center, Nijmegen, The Netherlands.; Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE),Bonn, Germany.; Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty ofMedicine, University of Bonn, Bonn, Germany.; Department I of Internal Medicine, University Hospital of Bonn (UKB), Bonn,Germany.; German Center for Infection Research (DZIF), Bonn, Germany.; 1st Department of Pulmonary Medicine and Intensive Care Unit, National andKapodistrian University of Athens, Medical School, Athens, Greece.; 4th Department of Internal Medicine, National and Kapodistrian University ofAthens, Medical School, Athens, Greece.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany. t.ulas@uni-bonn.de.; PRECISE Platform for Single Cell Genomics and Epigenomics at the German Centerfor Neurodegenerative Diseases and the University of Bonn, Bonn, Germany.t.ulas@uni-bonn.de.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Developmental Genetics \& Molecular Physiology, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Molecular Immunology in Neurodegeneration, German Center for NeurodegenerativeDiseases (DZNE), Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Molecular Immunology in Neurodegeneration, German Center for NeurodegenerativeDiseases (DZNE), Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Developmental Genetics \& Molecular Physiology, Life \& Medical Sciences (LIMES)Institute, University of Bonn, Bonn, Germany.; Developmental Biology of the Innate Immune System, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, the Netherlands.; Unit of Animal Genomics, GIGA-Institute, University of Liège, Liège, Belgium.; Unit of Animal Genomics, GIGA-Institute, University of Liège, Liège, Belgium.; Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Computational Biology for Individualised Infection Medicine, Centrefor Individualised Infection Medicine (CiiM) \& TWINCORE, joint ventures betweenthe Helmholtz-Centre for Infection Research (HZI) and the Hannover Medical School(MHH), Hannover, Germany.; Developmental Biology of the Innate Immune System, Life \& Medical Sciences(LIMES) Institute, University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; Molecular Immunology in Neurodegeneration, German Center for NeurodegenerativeDiseases (DZNE), Bonn, Germany.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, the Netherlands.; Immunology \& Metabolism, Life and Medical Sciences Institute (LIMES), Universityof Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform for SingleCell Genomics and Epigenomics at the DZNE and the University of Bonn, Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform for SingleCell Genomics and Epigenomics at the DZNE and the University of Bonn, Bonn,Germany.; Genomics and Immunoregulation, Life \& Medical Sciences (LIMES) Institute,University of Bonn, Bonn, Germany. a.aschenbrenner@uni-bonn.de.; Department of Internal Medicine and Radboud Center for Infectious Diseases (RCI),Radboud University Medical Center, Nijmegen, the Netherlands.a.aschenbrenner@uni-bonn.de.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin,Germany.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin,Germany; BIH Center for Regenerative Therapies, Charité, UniversitätsmedizinBerlin, and Berlin Institute of Health (BIH) Berlin, Germany.; Centre for Individualised Infection Medicine (CiiM) and TWINCORE, joint venturesbetween the Helmholtz-Centre for Infection Research (HZI) and the HannoverMedical School (MHH), Hannover, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center forInfection Research (HZI), Würzburg, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Centre for Individualised Infection Medicine (CiiM) and TWINCORE, joint venturesbetween the Helmholtz-Centre for Infection Research (HZI) and the HannoverMedical School (MHH), Hannover, Germany.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; Centre for Individualised Infection Medicine (CiiM) and TWINCORE, joint venturesbetween the Helmholtz-Centre for Infection Research (HZI) and the HannoverMedical School (MHH), Hannover, Germany.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center forInfection Research (HZI), Würzburg, Germany.; Mass Cytometry Lab, DRFZ Berlin, a Leibniz Institute, Berlin, Germany.; Mass Cytometry Lab, DRFZ Berlin, a Leibniz Institute, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Flow and Mass Cytometry Core Facility, Charité, Universitätsmedizin Berlin, andBerlin Institute of Health (BIH), Berlin, Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center forInfection Research (HZI), Würzburg, Germany.; Centre for Individualised Infection Medicine (CiiM) and TWINCORE, joint venturesbetween the Helmholtz-Centre for Infection Research (HZI) and the HannoverMedical School (MHH), Hannover, Germany; Department of Internal Medicine andRadboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, the Netherlands.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL).; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL).; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin,Germany; BIH Center for Regenerative Therapies, Charité, UniversitätsmedizinBerlin, and Berlin Institute of Health (BIH) Berlin, Germany; Department ofImmunology, Labor Berlin-Charité Vivantes, Berlin, Germany.; Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany;Berlin Institute of Health (BIH), Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for MolecularMedicine in the Helmholtz Association, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for MolecularMedicine in the Helmholtz Association, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany.; Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin,Germany.; Clinical Study Center (CSC), Charité, Universitätsmedizin Berlin, and BerlinInstitute of Health, Berlin, Germany.; Department of Immunology, Labor Berlin-Charité Vivantes, Berlin, Germany;Institute of Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry,Charité, Universitätsmedizin Berlin, Berlin, Germany.; Department of Immunology, Labor Berlin-Charité Vivantes, Berlin, Germany;Institute of Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry,Charité, Universitätsmedizin Berlin, Berlin, Germany.; Department of Immunology, Labor Berlin-Charité Vivantes, Berlin, Germany;Institute of Laboratory Medicine, Clinical Chemistry, and Pathobiochemistry,Charité, Universitätsmedizin Berlin, Berlin, Germany.; Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany.; Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin,Germany; Department of Immunology, Labor Berlin-Charité Vivantes, Berlin,Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Genome Analytics, Helmholtz-Center for Infection Research (HZI), Braunschweig,Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL).; Institute of Virology, Charité Universitätsmedizin Berlin, Berlin, Germany;German Center for Infection Research (DZIF).; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL).; Clinical Study Center (CSC), Charité, Universitätsmedizin Berlin, and BerlinInstitute of Health, Berlin, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany; Department of Tropical Medicine,Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany; I. Departmentof Medicine, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.; German Center for Neurodegenerative Diseases (DZNE), PRECISE Platform forGenomics and Epigenomics at DZNE, and University of Bonn, Bonn, Germany.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany; GermanCenter for Neurodegenerative Diseases (DZNE), PRECISE Platform for Genomics andEpigenomics at DZNE, and University of Bonn, Bonn, Germany. Electronic address:j.schultze@uni-bonn.de.; Life and Medical Sciences (LIMES) Institute, University of Bonn, Germany;Department of Internal Medicine and Radboud Center for Infectious Diseases,Radboud University Medical Center, Nijmegen, the Netherlands.; Centre for Individualised Infection Medicine (CiiM) and TWINCORE, joint venturesbetween the Helmholtz-Centre for Infection Research (HZI) and the HannoverMedical School (MHH), Hannover, Germany; Department of Internal Medicine andRadboud Center for Infectious Diseases, Radboud University Medical Center,Nijmegen, the Netherlands.; Department of Internal Medicine I, University Hospital Bonn, Bonn, Germany;German Center for Infection Research (DZIF).; Institute of Medical Immunology, Charité, Universitätsmedizin Berlin, Berlin,Germany.; Helmholtz Institute for RNA-based Infection Research (HIRI), Helmholtz-Center forInfection Research (HZI), Würzburg, Germany.; Department of Infectious Diseases and Respiratory Medicine, Charité,Universitätsmedizin Berlin, Berlin, Germany; German Center for Lung Research(DZL).; Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), Bonn,Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), Bonn,Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), Bonn,Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), Bonn,Germany.; Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases and University of Bonn, Bonn, Germany.; Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases and University of Bonn, Bonn, Germany.; Genomics and Immunoregulation, Life and Medical Sciences Institute (LIMES), Bonn,Germany.; Platform for Single Cell Genomics and Epigenomics, German Center forNeurodegenerative Diseases and University of Bonn, Bonn, Germany.},
    la = "eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng; eng",
    dep = "20240726; 20240703; 20240223; 20240405; 20231120; 20230929; 20230725; 20230526; 20230324; 20230216; 20221012; 20220922; 20220831; 20220728; 20211228; 20211216; 20210904; 20210526; 20210325; 20210324; 20210113; 20201216; 20201109; 20200805; 20190830",
    pl = "United States; United States; United States; England; Switzerland; United States; Switzerland; United States; United States; Switzerland; United States; United States; England; Switzerland; United States; England; United States; United States; England; Switzerland; England; England; United States; United States; United States; Switzerland",
    ta = "Cell Rep Med; Cell; J Vis Exp; Gut; Front Immunol; Cell Rep Methods; Front Immunol; Cell Rep; STAR Protoc; Front Immunol; iScience; Nat Immunol; Elife; Front Immunol; Cell; Nat Commun; Immunity; FASEB J; Nature; Front Immunol; J Mol Cell Cardiol; Genome Med; STAR Protoc; Nat Immunol; Cell; Front Immunol",
    jid = "101766894; 0413066; 101313252; 2985108R; 101560960; 9918227360606676; 101560960; 101573691; 101769501; 101560960; 101724038; 100941354; 101579614; 101560960; 0413066; 101528555; 9432918; 8804484; 0410462; 101560960; 0262322; 101475844; 101769501; 100941354; 0413066; 101560960",
    rn = "0 (Survival of Motor Neuron 1 Protein); 0 (Survival of Motor Neuron 2 Protein); 0 (SMN2 protein, human); 0 (SMN1 protein, human); 7S5I7G3JQL (Dexamethasone); 0 (Glucocorticoids); 0 (Carbohydrates); 0 (Anti-HIV Agents); 0 (Chromatin); 0 (Forkhead Transcription Factors); 0 (FOXP3 protein, human); 0 (MEOX1 protein, human); 0 (Transcription Factors); 0 (Homeodomain Proteins); 0 (Chromatin); 63231-63-0 (RNA); EC 2.7.7.- (Transposases); 0 (Chemotactic Factors); 0 (Proteome); 0 (Receptors, IgG); 0 (IFNA1 protein, human); 0 (Interferon-alpha); 0 (Tumor Necrosis Factor-alpha); 0 (CRELD2 protein, human); 0 (CRELD2 protein, mouse); 0 (Cell Adhesion Molecules); 0 (Extracellular Matrix Proteins); 0 (Biomarkers); 0 (CRELD1 protein, mouse); 0 (Cell Adhesion Molecules); 0 (Extracellular Matrix Proteins); 0 (Antiviral Agents); 63231-63-0 (RNA); 0 (Biomarkers); 0 (CRELD1 protein, human); 0 (CRELD1 protein, mouse); 0 (Cell Adhesion Molecules); 0 (Extracellular Matrix Proteins); 0 (CD11 Antigens); 0 (HLA-DR Antigens); 0 (Proteome)",
    sb = "IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM; IM",
    mh = "*Organoids/pathology/metabolism; Humans; *Muscular Atrophy, Spinal/pathology/genetics/metabolism; *Induced Pluripotent Stem Cells/metabolism/pathology; *Motor Neurons/pathology/metabolism; *Survival of Motor Neuron 1 Protein/genetics/metabolism; *Survival of Motor Neuron 2 Protein/genetics/metabolism; Animals; Mice; Spinal Cord/pathology/metabolism; Neural Stem Cells/metabolism/pathology; Humans; *Dexamethasone/pharmacology/therapeutic use; *Monocytes/metabolism/drug effects; *COVID-19 Drug Treatment; *COVID-19; *SARS-CoV-2/drug effects; Male; *Single-Cell Analysis; Female; Transcriptome; Middle Aged; Aged; Glucocorticoids/therapeutic use/pharmacology; Lung/pathology; Adult; *Transcriptome; Drug Evaluation, Preclinical; *Gene Expression Profiling; Gene Library; Costs and Cost Analysis; Humans; Mice; Animals; *Pulmonary Disease, Chronic Obstructive/etiology; Lung/metabolism/pathology; *Pneumonia/etiology; Inflammation/metabolism; Carbohydrates/pharmacology; Humans; *Anti-HIV Agents/therapeutic use; Cohort Studies; *HIV Infections; Monocytes; Multicenter Studies as Topic; *Chromatin/genetics; *Chromatin Immunoprecipitation Sequencing; Laser Capture Microdissection; Gene Expression Profiling; Freezing; Humans; *T-Lymphocytes, Regulatory; *Gene Expression Regulation; Gene Regulatory Networks; Forkhead Transcription Factors/genetics/metabolism; Transcription Factors/metabolism; Homeodomain Proteins/genetics; Humans; Animals; Mice; Neutrophils; *Pulmonary Disease, Chronic Obstructive/drug therapy; Lung; *Pulmonary Emphysema; Inflammation; Humans; *COVID-19/immunology; *Lung/immunology; Pandemics; SARS-CoV-2; *T-Lymphocytes/immunology; *Inflammation/immunology; Computer Simulation; *Immune System; *Machine Learning; *Chromatin; Precision Medicine; RNA; *Transcriptome; Transposases/metabolism; Chemotaxis/physiology; Humans; Macrophages/metabolism; *Macrophages, Alveolar; Monocytes/metabolism; *Pulmonary Disease, Chronic Obstructive; Adult; Aged; Aged, 80 and over; COVID-19/*immunology/*pathology/virology; Chemotactic Factors/metabolism; *Complement Activation; Cytotoxicity, Immunologic; Endothelial Cells/virology; Female; Humans; Lymphocyte Activation; Male; Microvessels/virology; Middle Aged; Monocytes/metabolism; Neutrophils/metabolism; *Proteome; Receptors, IgG/metabolism; SARS-CoV-2/*immunology; Single-Cell Analysis; T-Lymphocytes, Cytotoxic/*immunology; *Transcriptome; Young Adult; Animals; Blastocyst/cytology/metabolism; Cell Culture Techniques, Three Dimensional; Cellular Reprogramming; Embryo, Mammalian/embryology/metabolism; Embryoid Bodies/*cytology/metabolism; *Embryonic Development; Embryonic Stem Cells/*cytology/metabolism; Endoderm/embryology/metabolism; Gene Expression Regulation, Developmental; Mice; RNA-Seq; Base Sequence; COVID-19/*immunology; Humans; Immunity, Innate/immunology; Inflammation/immunology; Interferon-alpha/blood/*immunology; Killer Cells, Natural/*immunology; Pulmonary Fibrosis/pathology; RNA-Seq; SARS-CoV-2/*immunology; Severity of Illness Index; Transcriptome/genetics; Tumor Necrosis Factor-alpha/*metabolism; United Kingdom; United States; Aging; Animals; Cell Adhesion Molecules/*metabolism; Disease Progression; Endoplasmic Reticulum Stress; Extracellular Matrix Proteins/*metabolism; Fatty Liver; *Homeostasis; Humans; Liver/*metabolism; Male; Mice; Non-alcoholic Fatty Liver Disease; *Unfolded Protein Response; *Blockchain; COVID-19/diagnosis/epidemiology; Clinical Decision-Making/*methods; *Confidentiality; *Datasets as Topic; Disease Outbreaks; Female; Humans; Leukemia/diagnosis/pathology; Leukocytes/pathology; Lung Diseases/diagnosis; *Machine Learning/trends; Male; Precision Medicine/*methods; Software; Tuberculosis/diagnosis; COVID-19/*epidemiology/*immunology; Humans; Neutrophils/*immunology; *Pandemics; SARS-CoV-2/*immunology; Animals; Biomarkers; Cell Adhesion Molecules/*genetics/metabolism; Extracellular Matrix Proteins/*genetics/metabolism; Flow Cytometry; Gene Expression Profiling; *Gene Expression Regulation, Developmental; Heart/*embryology/*physiology; Humans; Mice, Knockout; Myocardium/*metabolism; Organogenesis/*genetics; Single-Cell Analysis; Mice; Antiviral Agents/therapeutic use; COVID-19/*pathology/virology; Case-Control Studies; Down-Regulation; Drug Repositioning; Humans; Neutrophils/cytology/immunology/*metabolism; Phenotype; Principal Component Analysis; RNA/blood/chemistry/metabolism; Sequence Analysis, RNA; Severity of Illness Index; *Transcriptome; Up-Regulation; COVID-19 Drug Treatment; Biomarkers/blood; *COVID-19/genetics/metabolism; *Communicable Diseases/genetics/metabolism; Humans; RNA-Seq/*methods; SARS-CoV-2; Single-Cell Analysis/*methods; Transcriptome/*genetics; Workflow; Animals; Cell Adhesion Molecules/genetics/*metabolism; Cell Survival/genetics/immunology; Extracellular Matrix Proteins/genetics/*metabolism; Gene Expression; Gene Knockout Techniques; *Homeostasis/immunology; Humans; Immune System/*immunology/*metabolism; *Immunomodulation; Immunosenescence; Lymphocyte Activation/genetics/immunology; Lymphocyte Count; Mice; T-Lymphocytes/immunology/metabolism; Wnt Signaling Pathway; Adult; Aged; CD11 Antigens/genetics/metabolism; COVID-19; Cells, Cultured; Coronavirus Infections/blood/*immunology/pathology; Female; HLA-DR Antigens/genetics/metabolism; Humans; Male; Middle Aged; Myeloid Cells/cytology/*immunology; *Myelopoiesis; Pandemics; Pneumonia, Viral/blood/*immunology/pathology; Proteome/genetics/metabolism; Proteomics; Single-Cell Analysis; Animals; Chronic Disease; Flow Cytometry/methods; Humans; Inflammation/*immunology; Monocytes/*immunology; Phenotype; Transcriptome/immunology",
    pmc = "PMC11384962; PMC10703486; PMC10626193; PMC10407399; PMC10320832; PMC10050770; PMC9977798; PMC9614568; PMC9433094; PMC9377018; PMC8712270; PMC8677818; PMC8416549; PMC8189907; PMC8027077; PMC7805430; PMC7757730; PMC7405822; PMC6728754",
    oto = "NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM; NOTNLM",
    cois = "Declaration of interests The authors declare no competing interests.; Declaration of interests The authors declare no competing interests.; Competing interests: None declared.; The authors declare that the research was conducted in the absence of anycommercial or financial relationships that could be construed as a potentialconflict of interest. The author(s) declared that they were an editorial boardmember of Frontiers, at the time of submission. This had no impact on the peerreview process and the final decision.; Declaration of interests The authors declare no competing interests.; The authors declare that the research was conducted in the absence of anycommercial or financial relationships that could be construed as a potentialconflict of interest.; Declaration of interests The authors have no competing interests.; Declaration of interests The authors declare no competing interests.; The authors declare that the research was conducted in the absence of anycommercial or financial relationships that could be construed as a potentialconflict of interest.; The authors declare that they have no competing interests.; CC, LB, JS, AH, MO, SW, TH, MD, KH, SM, TU, VG, RG, AA, JS, BG No competinginterests declared; The handling editor [AH] declared a shared affiliation with the author(s) [AW,NY] at the time of review. BR, FB, MK and HD were employed by CommaSoft. CW andPB were employed by Boehringer Ingelheim. The remaining authors declare that theresearch was conducted in the absence of any commercial or financialrelationships that could be constructed as a potential conflict of interest.; Declaration of interests V.M.C. is named together with Euroimmun GmbH on a patentapplication filed recently regarding SARS-CoV-2 diagnostics via antibody testing.A.R.S. and H.E.M. are listed as inventors on a patent application by the DRFZBerlin in the field of mass cytometry.; The authors declare no competing interests.; Declaration of interests P.-A.K. and F.I.S. are cofounders and shareholders ofDioscure Therapeutics SE. F.I.S. is a consultant and shareholder of IFMTherapeutics. J.R.H. is founder and board member of Isoplexis and PACT Pharma.J.D.G. declares contracted research with Gilead, Lilly, and Regeneron. K.H.,J.M.J., and A.J.B. work at Quanterix Corporation. All other authors declare nocompeting interests.; H.S., K.L.S., S. Manamohan, Saikat Mukherjee, V.G., R.S., C.S., M.D., B.M,C.M.S., S.C., M.S.W. and E.L.G. are employees of Hewlett Packard Enterprise.Hewlett Packard Enterprise developed the SLL in its entirety as described in thiswork and has submitted multiple associated patent applications. E.J.G.-B.received honoraria from AbbVie USA, Abbott CH, InflaRx GmbH, MSD Greece, XBiotechInc. and Angelini Italy and independent educational grants from AbbVie, Abbott,Astellas Pharma Europe, AxisShield, bioMérieux Inc, InflaRx GmbH, and XBiotechInc. All other authors declare no competing interests.; The authors declare that the research was conducted in the absence of anycommercial or financial relationships that could be construed as a potentialconflict of interest.; EJG-B has received honoraria (paid to the University of Athens) from AbbVie USA,Abbott CH, Angelini Italy, Biotest Germany, InflaRx GmbH, MSD Greece, andXBiotech Inc. He has received independent educational grants from AbbVie, Abbott,Astellas Pharma, AxisShield, bioMérieux Inc., InflaRx GmbH, and XBiotech Inc. Theremaining authors declare that they have no competing interests.; The authors declare no competing interests.; Declaration of Interests The authors declare no competing interests.",
    edat = "2024/07/28 14:51; 2024/07/05 00:42; 2024/03/11 12:42; 2024/02/09 00:42; 2023/12/11 12:41; 2023/10/01 04:44; 2023/08/10 06:43; 2023/05/27 19:14; 2023/03/26 06:00; 2023/03/07 06:00; 2022/11/01 06:00; 2022/09/23 06:00; 2022/09/01 06:00; 2022/08/19 06:00; 2022/01/16 06:00; 2021/12/18 06:00; 2021/10/01 06:00; 2021/09/23 06:00; 2021/05/28 06:00; 2021/04/13 06:00; 2021/03/29 06:00; 2021/01/15 06:00; 2020/12/31 06:00; 2020/11/11 06:00; 2020/08/19 06:00; 2019/09/24 06:00",
    mhda = "2024/08/22 00:42; 2024/08/10 15:43; 2024/03/12 06:43; 2024/04/08 06:42; 2023/12/17 13:19; 2023/10/30 06:46; 2023/08/11 06:42; 2023/10/04 06:43; 2023/03/26 06:00; 2023/03/08 06:00; 2022/11/01 06:01; 2022/10/13 06:00; 2022/09/03 06:00; 2022/08/20 06:00; 2022/02/11 06:00; 2022/01/07 06:00; 2021/11/24 06:00; 2021/10/28 06:00; 2021/06/22 06:00; 2021/04/20 06:00; 2022/01/11 06:00; 2021/01/22 06:00; 2020/12/31 06:01; 2021/02/16 06:00; 2020/10/02 06:00; 2020/09/30 06:00",
    pmcr = "2024/07/26; 2023/01/01; 2023/09/29; 2023/01/01; 2023/05/26; 2023/03/24; 2023/02/16; 2022/10/12; 2022/08/31; 2022/01/01; 2021/12/28; 2021/12/16; 2021/09/04; 2021/05/26; 2021/03/25; 2021/01/13; 2020/12/16; 2020/08/05; 2019/01/01",
    crdt = "2024/07/27 18:41; 2024/07/04 18:42; 2024/03/11 09:03; 2024/02/08 21:03; 2023/12/11 06:28; 2023/09/30 18:42; 2023/08/10 04:00; 2023/05/27 12:35; 2023/03/25 13:36; 2023/03/06 04:04; 2022/10/31 04:05; 2022/09/22 23:29; 2022/08/31 05:52; 2022/08/18 02:17; 2022/01/15 20:08; 2021/12/17 06:16; 2021/09/30 20:12; 2021/09/22 08:48; 2021/05/27 06:34; 2021/04/12 06:17; 2021/03/28 20:38; 2021/01/14 05:31; 2020/12/30 05:23; 2020/11/10 05:44; 2020/08/19 06:00; 2019/09/24 06:00",
    phst = "2023/07/25 00:00 [received]; 2024/02/26 00:00 [revised]; 2024/07/02 00:00 [accepted]; 2024/08/22 00:42 [medline]; 2024/07/28 14:51 [pubmed]; 2024/07/27 18:41 [entrez]; 2024/07/26 00:00 [pmc-release]; 2023/07/24 00:00 [received]; 2024/02/27 00:00 [revised]; 2024/06/10 00:00 [accepted]; 2024/08/10 15:43 [medline]; 2024/07/05 00:42 [pubmed]; 2024/07/04 18:42 [entrez]; 2024/03/12 06:43 [medline]; 2024/03/11 12:42 [pubmed]; 2024/03/11 09:03 [entrez]; 2023/06/18 00:00 [received]; 2024/01/08 00:00 [accepted]; 2024/04/08 06:42 [medline]; 2024/02/09 00:42 [pubmed]; 2024/02/08 21:03 [entrez]; 2023/08/09 00:00 [received]; 2023/10/18 00:00 [accepted]; 2023/12/17 13:19 [medline]; 2023/12/11 12:41 [pubmed]; 2023/12/11 06:28 [entrez]; 2023/01/01 00:00 [pmc-release]; 2023/03/27 00:00 [received]; 2023/08/04 00:00 [revised]; 2023/09/05 00:00 [accepted]; 2023/10/30 06:46 [medline]; 2023/10/01 04:44 [pubmed]; 2023/09/30 18:42 [entrez]; 2023/09/29 00:00 [pmc-release]; 2022/11/24 00:00 [received]; 2023/06/27 00:00 [accepted]; 2023/08/11 06:42 [medline]; 2023/08/10 06:43 [pubmed]; 2023/08/10 04:00 [entrez]; 2023/01/01 00:00 [pmc-release]; 2022/11/07 00:00 [received]; 2023/03/18 00:00 [revised]; 2023/05/01 00:00 [accepted]; 2023/10/04 06:43 [medline]; 2023/05/27 19:14 [pubmed]; 2023/05/27 12:35 [entrez]; 2023/05/26 00:00 [pmc-release]; 2022/12/14 00:00 [received]; 2023/01/29 00:00 [revised]; 2023/03/02 00:00 [accepted]; 2023/03/25 13:36 [entrez]; 2023/03/26 06:00 [pubmed]; 2023/03/26 06:00 [medline]; 2023/03/24 00:00 [pmc-release]; 2022/11/28 00:00 [received]; 2023/02/06 00:00 [accepted]; 2023/03/06 04:04 [entrez]; 2023/03/07 06:00 [pubmed]; 2023/03/08 06:00 [medline]; 2023/02/16 00:00 [pmc-release]; 2022/03/02 00:00 [received]; 2022/07/13 00:00 [revised]; 2022/10/07 00:00 [accepted]; 2022/10/31 04:05 [entrez]; 2022/11/01 06:00 [pubmed]; 2022/11/01 06:01 [medline]; 2022/10/12 00:00 [pmc-release]; 2021/12/20 00:00 [received]; 2022/08/09 00:00 [accepted]; 2022/09/23 06:00 [pubmed]; 2022/10/13 06:00 [medline]; 2022/09/22 23:29 [entrez]; 2022/02/18 00:00 [received]; 2022/08/15 00:00 [accepted]; 2022/08/31 05:52 [entrez]; 2022/09/01 06:00 [pubmed]; 2022/09/03 06:00 [medline]; 2022/08/31 00:00 [pmc-release]; 2022/04/10 00:00 [received]; 2022/06/24 00:00 [accepted]; 2022/08/18 02:17 [entrez]; 2022/08/19 06:00 [pubmed]; 2022/08/20 06:00 [medline]; 2022/01/01 00:00 [pmc-release]; 2021/06/07 00:00 [received]; 2021/10/22 00:00 [revised]; 2021/12/22 00:00 [accepted]; 2022/01/16 06:00 [pubmed]; 2022/02/11 06:00 [medline]; 2022/01/15 20:08 [entrez]; 2021/12/28 00:00 [pmc-release]; 2021/02/03 00:00 [received]; 2021/11/19 00:00 [accepted]; 2021/12/17 06:16 [entrez]; 2021/12/18 06:00 [pubmed]; 2022/01/07 06:00 [medline]; 2021/12/16 00:00 [pmc-release]; 2021/02/19 00:00 [received]; 2021/06/04 00:00 [revised]; 2021/08/31 00:00 [accepted]; 2021/10/01 06:00 [pubmed]; 2021/11/24 06:00 [medline]; 2021/09/30 20:12 [entrez]; 2021/09/04 00:00 [pmc-release]; 2021/09/02 00:00 [revised]; 2020/12/14 00:00 [received]; 2021/09/07 00:00 [accepted]; 2021/09/22 08:48 [entrez]; 2021/09/23 06:00 [pubmed]; 2021/10/28 06:00 [medline]; 2020/07/03 00:00 [received]; 2021/04/26 00:00 [accepted]; 2021/05/28 06:00 [pubmed]; 2021/06/22 06:00 [medline]; 2021/05/27 06:34 [entrez]; 2021/05/26 00:00 [pmc-release]; 2021/01/12 00:00 [received]; 2021/03/10 00:00 [accepted]; 2021/04/12 06:17 [entrez]; 2021/04/13 06:00 [pubmed]; 2021/04/20 06:00 [medline]; 2021/03/25 00:00 [pmc-release]; 2020/12/05 00:00 [received]; 2021/02/25 00:00 [revised]; 2021/03/18 00:00 [accepted]; 2021/03/29 06:00 [pubmed]; 2022/01/11 06:00 [medline]; 2021/03/28 20:38 [entrez]; 2020/07/15 00:00 [received]; 2020/12/18 00:00 [accepted]; 2021/01/14 05:31 [entrez]; 2021/01/15 06:00 [pubmed]; 2021/01/22 06:00 [medline]; 2021/01/13 00:00 [pmc-release]; 2020/12/30 05:23 [entrez]; 2020/12/31 06:00 [pubmed]; 2020/12/31 06:01 [medline]; 2020/12/16 00:00 [pmc-release]; 2019/09/13 00:00 [received]; 2020/09/16 00:00 [accepted]; 2020/11/11 06:00 [pubmed]; 2021/02/16 06:00 [medline]; 2020/11/10 05:44 [entrez]; 2020/05/27 00:00 [received]; 2020/07/13 00:00 [revised]; 2020/07/31 00:00 [accepted]; 2020/08/19 06:00 [pubmed]; 2020/10/02 06:00 [medline]; 2020/08/19 06:00 [entrez]; 2020/08/05 00:00 [pmc-release]; 2019/07/01 00:00 [received]; 2019/08/12 00:00 [accepted]; 2019/09/24 06:00 [entrez]; 2019/09/24 06:00 [pubmed]; 2020/09/30 06:00 [medline]; 2019/01/01 00:00 [pmc-release]",
    pst = "ppublish; ppublish; epublish; epublish; epublish; ppublish; epublish; ppublish; aheadofprint; epublish; epublish; ppublish; epublish; epublish; ppublish; epublish; ppublish; ppublish; ppublish; epublish; ppublish; epublish; epublish; ppublish; ppublish; epublish",
    so = "Cell Rep Med. 2024 Aug 20;5(8):101659. doi: 10.1016/j.xcrm.2024.101659. Epub 2024Jul 26.; Cell. 2024 Aug 8;187(16):4318-4335.e20. doi: 10.1016/j.cell.2024.06.014. Epub2024 Jul 3.; J Vis Exp. 2024 Feb 23;(204). doi: 10.3791/65930.; Gut. 2024 Apr 5;73(5):751-769. doi: 10.1136/gutjnl-2023-330521.; Front Immunol. 2023 Nov 20;14:1275136. doi: 10.3389/fimmu.2023.1275136.eCollection 2023.; Cell Rep Methods. 2023 Oct 23;3(10):100598. doi: 10.1016/j.crmeth.2023.100598.Epub 2023 Sep 29.; Front Immunol. 2023 Jul 25;14:1107397. doi: 10.3389/fimmu.2023.1107397.eCollection 2023.; Cell Rep. 2023 Jun 27;42(6):112525. doi: 10.1016/j.celrep.2023.112525. Epub 2023May 26.; STAR Protoc. 2023 Mar 24;4(2):102193. doi: 10.1016/j.xpro.2023.102193.; Front Immunol. 2023 Feb 16;14:1108716. doi: 10.3389/fimmu.2023.1108716.eCollection 2023.; iScience. 2022 Oct 12;25(11):105328. doi: 10.1016/j.isci.2022.105328. eCollection2022 Nov 18.; Nat Immunol. 2022 Oct;23(10):1412-1423. doi: 10.1038/s41590-022-01309-9. Epub2022 Sep 22.; Elife. 2022 Aug 31;11:e78012. doi: 10.7554/eLife.78012.; Front Immunol. 2022 Jul 28;13:917232. doi: 10.3389/fimmu.2022.917232. eCollection2022.; Cell. 2022 Feb 3;185(3):493-512.e25. doi: 10.1016/j.cell.2021.12.040. Epub 2021Dec 28.; Nat Commun. 2021 Dec 16;12(1):7322. doi: 10.1038/s41467-021-27586-w.; Immunity. 2021 Nov 9;54(11):2650-2669.e14. doi: 10.1016/j.immuni.2021.09.002.Epub 2021 Sep 4.; FASEB J. 2021 Oct;35(10):e21939. doi: 10.1096/fj.202002713RR.; Nature. 2021 Jun;594(7862):265-270. doi: 10.1038/s41586-021-03583-3. Epub 2021May 26.; Front Immunol. 2021 Mar 25;12:652470. doi: 10.3389/fimmu.2021.652470. eCollection2021.; J Mol Cell Cardiol. 2021 Jul;156:45-56. doi: 10.1016/j.yjmcc.2021.03.008. Epub2021 Mar 24.; Genome Med. 2021 Jan 13;13(1):7. doi: 10.1186/s13073-020-00823-5.; STAR Protoc. 2020 Dec 16;1(3):100233. doi: 10.1016/j.xpro.2020.100233.eCollection 2020 Dec 18.; Nat Immunol. 2020 Dec;21(12):1517-1527. doi: 10.1038/s41590-020-00811-2. Epub2020 Nov 9.; Cell. 2020 Sep 17;182(6):1419-1440.e23. doi: 10.1016/j.cell.2020.08.001. Epub2020 Aug 5.; Front Immunol. 2019 Aug 30;10:2035. doi: 10.3389/fimmu.2019.02035. eCollection2019.",
    cn = "CAPNETZ Study Group; Pa-COVID-19 Study Group; PA-COVID-19 Study Group; Deutsche COVID-19 OMICS Initiative (DeCOI); COVID-19 Aachen Study (COVAS); Deutsche COVID-19 Omics Initiative (DeCOI); German COVID-19 Omics Initiative (DeCOI); Deutsche COVID-19 OMICS Initiative (DeCOI)",
    auid = "ORCID: 0000-0002-7435-275X; ORCID: 0000-0002-5796-0171; ORCID: 0000-0003-2339-114X; ORCID: 0000-0001-5890-7877; ORCID: 0000-0002-7361-2337; ORCID: 0000-0002-1001-2019; ORCID: 0000-0001-8512-7593; ORCID: 0000-0001-6269-355X; ORCID: 0000-0003-1740-3538; ORCID: 0000-0003-4558-329X; ORCID: 0000-0002-1004-1936; ORCID: 0000-0002-3619-7410; ORCID: 0000-0002-7244-6058; ORCID: 0000-0003-3641-2499; ORCID: 0000-0003-2315-7089; ORCID: 0000-0002-0159-6649; ORCID: 0000-0002-8587-1774; ORCID: 0000-0002-1248-9590; ORCID: 0000-0002-2371-7990; ORCID: 0000-0002-9660-9587; ORCID: 0000-0002-8526-0631; ORCID: 0000-0001-7269-7773; ORCID: 0000-0003-4151-3470; ORCID: 0000-0003-2047-6543; ORCID: 0000-0001-6817-9690; ORCID: 0000-0002-3877-9772; ORCID: 0000-0001-5366-4554; ORCID: 0000-0002-0995-0171; ORCID: 0000-0001-9675-7208; ORCID: 0000-0003-2812-9853; ORCID: 0000-0003-4892-3691; ORCID: 0000-0003-4144-2537; ORCID: 0000-0003-4144-2537; ORCID: 0000-0003-3559-9431; ORCID: 0000-0002-5273-8213; ORCID: 0000-0002-6507-1403; ORCID: 0000-0001-8338-1993; ORCID: 0000-0001-5676-6126; ORCID: 0000-0002-4895-3105; ORCID: 0000-0001-5386-7925; ORCID: 0000-0002-4741-3035; ORCID: 0000-0001-9675-7208; ORCID: 0000-0002-9785-4197; ORCID: 0000-0003-2812-9853; ORCID: 0000-0002-3039-4675; ORCID: 0000-0001-9675-7208; ORCID: 0000-0002-1284-3254; ORCID: 0000-0002-9429-5457; ORCID: 0000-0001-9465-6913; ORCID: 0000-0001-9675-7208; ORCID: 0000-0001-6238-1273; ORCID: 0000-0002-7120-4508; ORCID: 0000-0001-5625-0701; ORCID: 0000-0002-7783-6602; ORCID: 0000-0001-8272-0076; ORCID: 0000-0003-2318-2356; ORCID: 0000-0002-0890-5774; ORCID: 0000-0001-5008-7851; ORCID: 0000-0002-3612-6276; ORCID: 0000-0001-5133-5896; ORCID: 0000-0001-6184-458X; ORCID: 0000-0002-3735-9872; ORCID: 0000-0003-2209-0580; ORCID: 0000-0001-9422-6569; ORCID: 0000-0002-8223-3750; ORCID: 0000-0003-1967-2918; ORCID: 0000-0002-2300-9337; ORCID: 0000-0001-9675-7208; ORCID: 0000-0003-0336-8284; ORCID: 0000-0002-2991-9307; ORCID: 0000-0001-6339-2521; ORCID: 0000-0002-5642-8378; ORCID: 0000-0002-5361-0895; ORCID: 0000-0003-2421-6052; ORCID: 0000-0002-2419-1943; ORCID: 0000-0002-9429-5457; ORCID: 0000-0002-9785-4197; ORCID: 0000-0002-0626-9305; ORCID: 0000-0003-4713-3911; ORCID: 0000-0001-6537-6971; ORCID: 0000-0002-7120-4508; ORCID: 0000-0002-3449-9634; ORCID: 0000-0003-2812-9853; ORCID: 0000-0002-9785-4197; ORCID: 0000-0001-9675-7208; ORCID: 0000-0001-7333-8924; ORCID: 0000-0002-1722-9974; ORCID: 0000-0002-9135-7819; ORCID: 0000-0003-4124-2375; ORCID: 0000-0003-2318-2356; ORCID: 0000-0001-9704-148X; ORCID: 0000-0001-6166-9830; ORCID: 0000-0003-2421-6052; ORCID: 0000-0002-9785-4197; ORCID: 0000-0003-2812-9853; ORCID: 0000-0002-9429-5457",
    cin = "Front Immunol. 2023 Dec 20;14:1297577. doi: 10.3389/fimmu.2023.1297577. PMID:38187374; J Allergy Clin Immunol. 2022 Apr;149(4):1223-1224. doi:10.1016/j.jaci.2022.01.002. PMID: 35051507; Nat Immunol. 2020 Dec;21(12):1480-1482. doi: 10.1038/s41590-020-00820-1. PMID:33169012",
    si = "GEO/GSE179064; GEO/GSE207612; GEO/GSE179057; GEO/GSE179059; GEO/GSE207611; GEO/GSE207607; figshare/10.6084/m9.figshare.16530759.v1; figshare/10.6084/m9.figshare.16406601.v1",
    uof = "doi: 10.1101/2022.02.21.481294",
    gr = "U19 MH114821/MH/NIMH NIH HHS/United States; U54 CA217377/CA/NCI NIH HHS/United States; U24 AI118672/AI/NIAID NIH HHS/United States; WT\_/Wellcome Trust/United Kingdom; FC001134/ARC\_/Arthritis Research UK/United Kingdom",
    ifn = "α-induced NK cell response with poorer disease outcome.",
    fir = "Altmüller, Janine; Angelov, Angel; Aschenbrenner, Anna C; Bals, Robert; Bartholomäus, Alexander; Becker, Anke; Becker, Matthias; Bezdan, Daniela; Bitzer, Michael; Blumert, Conny; Bonifacio, Ezio; Bork, Peer; Boyke, Bunk; Blum, Helmut; Casadei, Nicolas; Clavel, Thomas; Colome-Tatche, Maria; Cornberg, Markus; De La Rosa Velázquez, Inti Alberto; Diefenbach, Andreas; Dilthey, Alexander; Fischer, Nicole; Förstner, Konrad; Franzenburg, Sören; Frick, Julia-Stefanie; Gabernet, Gisela; Gagneur, Julien; Ganzenmueller, Tina; Gauder, Marie; Geißert, Janina; Goesmann, Alexander; Göpel, Siri; Grundhoff, Adam; Grundmann, Hajo; Hain, Torsten; Hanses, Frank; Hehr, Ute; Heimbach, André; Hoeper, Marius; Horn, Friedemann; Hübschmann, Daniel; Hummel, Michael; Iftner, Thomas; Iftner, Angelika; Illig, Thomas; Janssen, Stefan; Kalinowski, Jörn; Kallies, René; Kehr, Birte; Keller, Andreas; Keppler, Oliver T; Kim-Hellmuth, Sarah; Klein, Christoph; Knop, Michael; Kohlbacher, Oliver; Köhrer, Karl; Korbel, Jan; Kremsner, Peter G; Kühnert, Denise; Kurth, Ingo; Landthaler, Markus; Li, Yang; Ludwig, Kerstin U; Makarewicz, Oliwia; Marini, Federico; Marz, Manja; McHardy, Alice C; Mertes, Christian; Münchhoff, Maximilian; Nahnsen, Sven; Nöthen, Markus; Ntoumi, Francine; Nürnberg, Peter; Ossowski, Stephan; Overmann, Jörg; Peter, Silke; Pfeffer, Klaus; Pink, Isabell; Poetsch, Anna R; Protzer, Ulrike; Pühler, Alfred; Rajewsky, Nikolaus; Ralser, Markus; Reiche, Kristin; Rieß, Olaf; Ripke, Stephan; Nunes da Rocha, Ulisses; Rosenstiel, Philip; Saliba, Antoine-Emmanuel; Sander, Leif Erik; Sawitzki, Birgit; Scheithauer, Simone; Schiffer, Philipp; Schmid-Burgk, Jonathan; Schneider, Wulf; Schulte, Eva-Christina; Schultze, Joachim L; Sczyrba, Alexander; Sharaf, Mariam L; Singh, Yogesh; Sonnabend, Michael; Stegle, Oliver; Stoye, Jens; Theis, Fabian; Ulas, Thomas; Vehreschild, Janne; Velavan, Thirumalaisamy P; Vogel, Jörg; Volland, Sonja; von Kleist, Max; Walker, Andreas; Walter, Jörn; Wieczorek, Dagmar; Winkler, Sylke; Ziebuhr, John; Balfanz, Paul; Eggermann, Thomas; Boor, Peter; Hausmann, Ralf; Kuhn, Hannah; Isfort, Susanne; Stingl, Julia Carolin; Schmalzing, Günther; Kuhl, Christiane K; Röhrig, Rainer; Marx, Gernot; Uhlig, Stefan; Dahl, Edgar; Müller-Wieland, Dirk; Dreher, Michael; Marx, Nikolaus; Angelov, Angel; Bartholomäus, Alexander; Becker, Anke; Bezdan, Daniela; Blumert, Conny; Bonifacio, Ezio; Bork, Peer; Boyke, Bunk; Blum, Helmut; Clavel, Thomas; Colome-Tatche, Maria; Cornberg, Markus; De La Rosa Velázquez, Inti Alberto; Diefenbach, Andreas; Dilthey, Alexander; Fischer, Nicole; Förstner, Konrad; Franzenburg, Sören; Frick, Julia-Stefanie; Gabernet, Gisela; Gagneur, Julien; Ganzenmueller, Tina; Gauder, Marie; Geißert, Janina; Goesmann, Alexander; Göpel, Siri; Grundhoff, Adam; Grundmann, Hajo; Hain, Torsten; Hanses, Frank; Hehr, Ute; Heimbach, André; Hoeper, Marius; Horn, Friedemann; Hübschmann, Daniel; Hummel, Michael; Iftner, Thomas; Iftner, Angelika; Illig, Thomas; Janssen, Stefan; Kalinowski, Jörn; Kallies, René; Kehr, Birte; Keppler, Oliver T; Klein, Christoph; Knop, Michael; Kohlbacher, Oliver; Köhrer, Karl; Korbel, Jan; Kremsner, Peter G; Kühnert, Denise; Landthaler, Markus; Li, Yang; Ludwig, Kerstin U; Makarewicz, Oliwia; Marz, Manja; McHardy, Alice C; Mertes, Christian; Münchhoff, Maximilian; Nahnsen, Sven; Nöthen, Markus; Ntoumi, Francine; Overmann, Jörg; Peter, Silke; Pfeffer, Klaus; Pink, Isabell; Poetsch, Anna R; Protzer, Ulrike; Pühler, Alfred; Rajewsky, Nikolaus; Ralser, Markus; Reiche, Kristin; Ripke, Stephan; da Rocha, Ulisses Nunes; Saliba, Antoine-Emmanuel; Sander, Leif Erik; Sawitzki, Birgit; Scheithauer, Simone; Schiffer, Philipp; Schmid-Burgk, Jonathan; Schneider, Wulf; Schulte, Eva-Christina; Sczyrba, Alexander; Sharaf, Mariam L; Singh, Yogesh; Sonnabend, Michael; Stegle, Oliver; Stoye, Jens; Vehreschild, Janne; Velavan, Thirumalaisamy P; Vogel, Jörg; Volland, Sonja; von Kleist, Max; Walker, Andreas; Walter, Jörn; Wieczorek, Dagmar; Winkler, Sylke; Ziebuhr, John; Altmüller, Janine; Angelov, Angel; Bals, Robert; Bartholomäus, Alexander; Becker, Anke; Bitzer, Michael; Bonifacio, Ezio; Bork, Peer; Casadei, Nicolas; Clavel, Thomas; Colome-Tatche, Maria; Diefenbach, Andreas; Dilthey, Alexander; Fischer, Nicole; Förstner, Konrad; Franzenburg, Sören; Frick, Julia-Stefanie; Gabernet, Gisela; Gagneur, Julien; Ganzenmüller, Tina; Göpel, Siri; Goesmann, Alexander; Hain, Torsten; Heimbach, André; Hummel, Michael; Iftner, Angelika; Iftner, Thomas; Janssen, Stefan; Kalinowski, Jörn; Kallies, René; Kehr, Birte; Keller, Andreas; Kim-Hellmuth, Sarah; Klein, Christoph; Kohlbacher, Oliver; Köhrer, Karl; Korbel, Jan; Kühnert, Denise; Kurth, Ingo; Landthaler, Markus; Li, Yang; Ludwig, Kerstin; Makarewicz, Oliwia; Marz, Manja; McHardy, Alice; Mertes, Christian; Nöthen, Markus; Nürnberg, Peter; Ohler, Uwe; Ossowski, Stephan; Overmann, Jörg; Pfeffer, Klaus; Poetsch, Anna R; Pühler, Alfred; Rajewsky, Nikolaus; Ralser, Markus; Rieß, Olaf; Ripke, Stephan; Nunes da Rocha, Ulisses; Rosenstiel, Philip; Saliba, Antoine-Emmanuel; Sander, Leif Erik; Sawitzki, Birgit; Schiffer, Philipp; Schneider, Wulf; Schulte, Eva-Christina; Schultze, Joachim L; Sczyrba, Alexander; Singh, Yogesh; Sonnabend, Michael; Stegle, Oliver; Stoye, Jens; Theis, Fabian; Vehreschild, Janne; Vogel, Jörg; von Kleist, Max; Walker, Andreas; Walter, Jörn; Wieczorek, Dagmar; Winkler, Sylke; Ziebuhr, John; Angelov, Angel; Bals, Robert; Bartholomäus, Alexander; Becker, Anke; Bezdan, Daniela; Bonifacio, Ezio; Bork, Peer; Clavel, Thomas; Colome-Tatche, Maria; Diefenbach, Andreas; Dilthey, Alexander; Fischer, Nicole; Förstner, Konrad; Frick, Julia-Stefanie; Gagneur, Julien; Goesmann, Alexander; Hain, Torsten; Hummel, Michael; Janssen, Stefan; Kalinowski, Jörn; Kallies, René; Kehr, Birte; Keller, Andreas; Kim-Hellmuth, Sarah; Klein, Christoph; Kohlbacher, Oliver; Korbel, Jan O; Kurth, Ingo; Landthaler, Markus; Li, Yang; Ludwig, Kerstin; Makarewicz, Oliwia; Marz, Manja; McHardy, Alice; Mertes, Christian; Nöthen, Markus; Nürnberg, Peter; Ohler, Uwe; Ossowski, Stephan; Overmann, Jörg; Peter, Silke; Pfeffer, Klaus; Poetsch, Anna R; Pühler, Alfred; Rajewsky, Nikolaus; Ralser, Markus; Rieß, Olaf; Ripke, Stephan; Nunes da Rocha, Ulisses; Rosenstiel, Philip; Saliba, Antoine-Emmanuel; Sander, Leif Erik; Sawitzki, Birgit; Schiffer, Philipp; Schulte, Eva-Christina; Schultze, Joachim L; Sczyrba, Alexander; Stegle, Oliver; Stoye, Jens; Theis, Fabian; Vehreschild, Janne; Vogel, Jörg; von Kleist, Max; Walker, Andreas; Walter, Jörn; Wieczorek, Dagmar; Ziebuhr, John",
    ir = "Altmüller J; Angelov A; Aschenbrenner AC; Bals R; Bartholomäus A; Becker A; Becker M; Bezdan D; Bitzer M; Blumert C; Bonifacio E; Bork P; Boyke B; Blum H; Casadei N; Clavel T; Colome-Tatche M; Cornberg M; De La Rosa Velázquez IA; Diefenbach A; Dilthey A; Fischer N; Förstner K; Franzenburg S; Frick JS; Gabernet G; Gagneur J; Ganzenmueller T; Gauder M; Geißert J; Goesmann A; Göpel S; Grundhoff A; Grundmann H; Hain T; Hanses F; Hehr U; Heimbach A; Hoeper M; Horn F; Hübschmann D; Hummel M; Iftner T; Iftner A; Illig T; Janssen S; Kalinowski J; Kallies R; Kehr B; Keller A; Keppler OT; Kim-Hellmuth S; Klein C; Knop M; Kohlbacher O; Köhrer K; Korbel J; Kremsner PG; Kühnert D; Kurth I; Landthaler M; Li Y; Ludwig KU; Makarewicz O; Marini F; Marz M; McHardy AC; Mertes C; Münchhoff M; Nahnsen S; Nöthen M; Ntoumi F; Nürnberg P; Ossowski S; Overmann J; Peter S; Pfeffer K; Pink I; Poetsch AR; Protzer U; Pühler A; Rajewsky N; Ralser M; Reiche K; Rieß O; Ripke S; Nunes da Rocha U; Rosenstiel P; Saliba AE; Sander LE; Sawitzki B; Scheithauer S; Schiffer P; Schmid-Burgk J; Schneider W; Schulte EC; Schultze JL; Sczyrba A; Sharaf ML; Singh Y; Sonnabend M; Stegle O; Stoye J; Theis F; Ulas T; Vehreschild J; Velavan TP; Vogel J; Volland S; von Kleist M; Walker A; Walter J; Wieczorek D; Winkler S; Ziebuhr J; Balfanz P; Eggermann T; Boor P; Hausmann R; Kuhn H; Isfort S; Stingl JC; Schmalzing G; Kuhl CK; Röhrig R; Marx G; Uhlig S; Dahl E; Müller-Wieland D; Dreher M; Marx N; Angelov A; Bartholomäus A; Becker A; Bezdan D; Blumert C; Bonifacio E; Bork P; Boyke B; Blum H; Clavel T; Colome-Tatche M; Cornberg M; De La Rosa Velázquez IA; Diefenbach A; Dilthey A; Fischer N; Förstner K; Franzenburg S; Frick JS; Gabernet G; Gagneur J; Ganzenmueller T; Gauder M; Geißert J; Goesmann A; Göpel S; Grundhoff A; Grundmann H; Hain T; Hanses F; Hehr U; Heimbach A; Hoeper M; Horn F; Hübschmann D; Hummel M; Iftner T; Iftner A; Illig T; Janssen S; Kalinowski J; Kallies R; Kehr B; Keppler OT; Klein C; Knop M; Kohlbacher O; Köhrer K; Korbel J; Kremsner PG; Kühnert D; Landthaler M; Li Y; Ludwig KU; Makarewicz O; Marz M; McHardy AC; Mertes C; Münchhoff M; Nahnsen S; Nöthen M; Ntoumi F; Overmann J; Peter S; Pfeffer K; Pink I; Poetsch AR; Protzer U; Pühler A; Rajewsky N; Ralser M; Reiche K; Ripke S; da Rocha UN; Saliba AE; Sander LE; Sawitzki B; Scheithauer S; Schiffer P; Schmid-Burgk J; Schneider W; Schulte EC; Sczyrba A; Sharaf ML; Singh Y; Sonnabend M; Stegle O; Stoye J; Vehreschild J; Velavan TP; Vogel J; Volland S; von Kleist M; Walker A; Walter J; Wieczorek D; Winkler S; Ziebuhr J; Altmüller J; Angelov A; Bals R; Bartholomäus A; Becker A; Bitzer M; Bonifacio E; Bork P; Casadei N; Clavel T; Colome-Tatche M; Diefenbach A; Dilthey A; Fischer N; Förstner K; Franzenburg S; Frick JS; Gabernet G; Gagneur J; Ganzenmüller T; Göpel S; Goesmann A; Hain T; Heimbach A; Hummel M; Iftner A; Iftner T; Janssen S; Kalinowski J; Kallies R; Kehr B; Keller A; Kim-Hellmuth S; Klein C; Kohlbacher O; Köhrer K; Korbel J; Kühnert D; Kurth I; Landthaler M; Li Y; Ludwig K; Makarewicz O; Marz M; McHardy A; Mertes C; Nöthen M; Nürnberg P; Ohler U; Ossowski S; Overmann J; Pfeffer K; Poetsch AR; Pühler A; Rajewsky N; Ralser M; Rieß O; Ripke S; Nunes da Rocha U; Rosenstiel P; Saliba AE; Sander LE; Sawitzki B; Schiffer P; Schneider W; Schulte EC; Schultze JL; Sczyrba A; Singh Y; Sonnabend M; Stegle O; Stoye J; Theis F; Vehreschild J; Vogel J; von Kleist M; Walker A; Walter J; Wieczorek D; Winkler S; Ziebuhr J; Angelov A; Bals R; Bartholomäus A; Becker A; Bezdan D; Bonifacio E; Bork P; Clavel T; Colome-Tatche M; Diefenbach A; Dilthey A; Fischer N; Förstner K; Frick JS; Gagneur J; Goesmann A; Hain T; Hummel M; Janssen S; Kalinowski J; Kallies R; Kehr B; Keller A; Kim-Hellmuth S; Klein C; Kohlbacher O; Korbel JO; Kurth I; Landthaler M; Li Y; Ludwig K; Makarewicz O; Marz M; McHardy A; Mertes C; Nöthen M; Nürnberg P; Ohler U; Ossowski S; Overmann J; Peter S; Pfeffer K; Poetsch AR; Pühler A; Rajewsky N; Ralser M; Rieß O; Ripke S; Nunes da Rocha U; Rosenstiel P; Saliba AE; Sander LE; Sawitzki B; Schiffer P; Schulte EC; Schultze JL; Sczyrba A; Stegle O; Stoye J; Theis F; Vehreschild J; Vogel J; von Kleist M; Walker A; Walter J; Wieczorek D; Ziebuhr J",
    rna = "sequencing, and flow cytometry, we demonstrate that Creld1 function in theendocardium is dispensable for heart development. Lack of myocardial Creld1causes extracellular matrix remodeling and trabeculation defects by modulation ofthe Notch1 signaling pathway. Hence, KO(MyHC) mice die early postnatally due tomyocardial hypoplasia. Our results reveal that Creld1 not only controls theformation of septa and valves at an early stage during heart development, butalso cardiac maturation and function at a later stage. These findings underlinethe central role of Creld1 in mammalian heart development and function.",
    aid = "S2666-3791(24)00373-2 [pii]; 101659 [pii]; S0092-8674(24)00654-8 [pii]; gutjnl-2023-330521 [pii]; S2667-2375(23)00250-3 [pii]; 100598 [pii]; S2211-1247(23)00536-3 [pii]; 112525 [pii]; S2666-1667(23)00151-X [pii]; 102193 [pii]; S2589-0042(22)01600-5 [pii]; 105328 [pii]; 10.1038/s41590-022-01309-9 [pii]; 78012 [pii]; S0092-8674(21)01562-2 [pii]; 10.1038/s41467-021-27586-w [pii]; 27586 [pii]; S1074-7613(21)00365-4 [pii]; 10.1038/s41586-021-03583-3 [pii]; 3583 [pii]; S0022-2828(21)00065-1 [pii]; 10.1186/s13073-020-00823-5 [pii]; 823 [pii]; S2666-1667(20)30220-3 [pii]; 100233 [pii]; 10.1038/s41590-020-00811-2 [pii]; S0092-8674(20)30992-2 [pii]"
}
